
<html lang="en"     class="pb-page"  data-request-id="fd4188f4-65cb-4ff2-b7e3-edc4b0221005"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2019.62.issue-17;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b00340;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators" /></meta><meta name="dc.Creator" content="Anthony B.  Pinkerton" /></meta><meta name="dc.Creator" content="Satyamaheshwar  Peddibhotla" /></meta><meta name="dc.Creator" content="Fusayo  Yamamoto" /></meta><meta name="dc.Creator" content="Lauren M.  Slosky" /></meta><meta name="dc.Creator" content="Yushi  Bai" /></meta><meta name="dc.Creator" content="Patrick  Maloney" /></meta><meta name="dc.Creator" content="Paul  Hershberger" /></meta><meta name="dc.Creator" content="Michael P.  Hedrick" /></meta><meta name="dc.Creator" content="Bekhi  Falter" /></meta><meta name="dc.Creator" content="Robert J.  Ardecky" /></meta><meta name="dc.Creator" content="Layton H.  Smith" /></meta><meta name="dc.Creator" content="Thomas D. Y.  Chung" /></meta><meta name="dc.Creator" content="Michael R.  Jackson" /></meta><meta name="dc.Creator" content="Marc G.  Caron" /></meta><meta name="dc.Creator" content="Lawrence S.  Barak" /></meta><meta name="dc.Description" content="Neurotensin receptor 1 (NTR1) is a G protein coupled receptor that is widely expressed throughout the central nervous system where it acts as a neuromodulator. Neurotensin receptors have been impli..." /></meta><meta name="Description" content="Neurotensin receptor 1 (NTR1) is a G protein coupled receptor that is widely expressed throughout the central nervous system where it acts as a neuromodulator. Neurotensin receptors have been impli..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 7, 2019" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00340" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00340" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00340" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00340" /></link>
        
    
    

<title>Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00340" /></meta><meta property="og:title" content="Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0014.jpeg" /></meta><meta property="og:description" content="Neurotensin receptor 1 (NTR1) is a G protein coupled receptor that is widely expressed throughout the central nervous system where it acts as a neuromodulator. Neurotensin receptors have been implicated in a wide variety of CNS disorders, but despite extensive efforts to develop small molecule ligands there are few reports of such compounds. Herein we describe the optimization of a quinazoline based lead to give 18 (SBI-553), a potent and brain penetrant NTR1 allosteric modulator." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00340"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00340">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00340&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00340&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00340&amp;href=/doi/10.1021/acs.jmedchem.9b00340" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 8357-8363</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01342" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/acs.jmedchem.9b01259" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Anthony B. Pinkerton</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anthony B. Pinkerton</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 01-858-795-5320. E-mail: <a href="/cdn-cgi/l/email-protection#4a2b3a2324212f383e25240a39283a2e233929253c2f38336425382d"><span class="__cf_email__" data-cfemail="1a7b6a7374717f686e75745a69786a7e736979756c7f68633475687d">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anthony+B.++Pinkerton">Anthony B. Pinkerton</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4571-152X" title="Orcid link">http://orcid.org/0000-0003-4571-152X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Satyamaheshwar Peddibhotla</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Satyamaheshwar Peddibhotla</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Satyamaheshwar++Peddibhotla">Satyamaheshwar Peddibhotla</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fusayo Yamamoto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fusayo Yamamoto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fusayo++Yamamoto">Fusayo Yamamoto</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lauren M. Slosky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lauren M. Slosky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Duke University Medical Center, Durham, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lauren+M.++Slosky">Lauren M. Slosky</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9471-9117" title="Orcid link">http://orcid.org/0000-0002-9471-9117</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yushi Bai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yushi Bai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Duke University Medical Center, Durham, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yushi++Bai">Yushi Bai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Patrick Maloney</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Patrick Maloney</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Patrick++Maloney">Patrick Maloney</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paul Hershberger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paul Hershberger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Hershberger">Paul Hershberger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael P. Hedrick</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael P. Hedrick</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+P.++Hedrick">Michael P. Hedrick</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bekhi Falter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bekhi Falter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bekhi++Falter">Bekhi Falter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Robert J. Ardecky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert J. Ardecky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+J.++Ardecky">Robert J. Ardecky</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Layton H. Smith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Layton H. Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Layton+H.++Smith">Layton H. Smith</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas D. Y. Chung</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas D. Y. Chung</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+D.+Y.++Chung">Thomas D. Y. Chung</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael R. Jackson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael R. Jackson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Conrad Prebys Center for Chemical Genomics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+R.++Jackson">Michael R. Jackson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc G. Caron</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc G. Caron</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Duke University Medical Center, Durham, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc+G.++Caron">Marc G. Caron</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Lawrence S. Barak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lawrence S. Barak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Duke University Medical Center, Durham, North Carolina 27709, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence+S.++Barak">Lawrence S. Barak</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9170-2141" title="Orcid link">http://orcid.org/0000-0002-9170-2141</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00340&amp;href=/doi/10.1021%2Facs.jmedchem.9b00340" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 8357–8363</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 7, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 February 2019</li><li><span class="item_label"><b>Published</b> online</span>7 August 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 September 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00340" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00340</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8357%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAnthony%2BB.%2BPinkerton%252C%2BSatyamaheshwar%2BPeddibhotla%252C%2BFusayo%2BYamamoto%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D17%26contentID%3Dacs.jmedchem.9b00340%26title%3DDiscovery%2Bof%2B%25CE%25B2-Arrestin%2BBiased%252C%2BOrally%2BBioavailable%252C%2Band%2BCNS%2BPenetrant%2BNeurotensin%2BReceptor%2B1%2B%2528NTR1%2529%2BAllosteric%2BModulators%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8363%26publicationDate%3DSeptember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00340"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2364</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">7</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00340" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of β-Arrestin Biased, Orally Bioavailable, and CNS Penetrant Neurotensin Receptor 1 (NTR1) Allosteric Modulators&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;B. Pinkerton&quot;},{&quot;first_name&quot;:&quot;Satyamaheshwar&quot;,&quot;last_name&quot;:&quot;Peddibhotla&quot;},{&quot;first_name&quot;:&quot;Fusayo&quot;,&quot;last_name&quot;:&quot;Yamamoto&quot;},{&quot;first_name&quot;:&quot;Lauren&quot;,&quot;last_name&quot;:&quot;M. Slosky&quot;},{&quot;first_name&quot;:&quot;Yushi&quot;,&quot;last_name&quot;:&quot;Bai&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;Maloney&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Hershberger&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;P. Hedrick&quot;},{&quot;first_name&quot;:&quot;Bekhi&quot;,&quot;last_name&quot;:&quot;Falter&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;J. Ardecky&quot;},{&quot;first_name&quot;:&quot;Layton&quot;,&quot;last_name&quot;:&quot;H. Smith&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;D. Y. Chung&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;R. Jackson&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;G. Caron&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;S. Barak&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;8357-8363&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00340&quot;},&quot;abstract&quot;:&quot;Neurotensin receptor 1 (NTR1) is a G protein coupled receptor that is widely expressed throughout the central nervous system where it acts as a neuromodulator. Neurotensin receptors have been implicated in a wide variety of CNS disorders, but despite extensive efforts to develop small molecule ligands there are few reports of such compounds. Herein we describe the optimization of a quinazoline based lead to give 18 (SBI-553), a potent and brain penetrant NTR1 allosteric modulator.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00340&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00340" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00340&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00340" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00340&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00340" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00340&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00340&amp;href=/doi/10.1021/acs.jmedchem.9b00340" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00340" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00340" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00340%26sid%3Dliteratum%253Aachs%26pmid%3D31390201%26genre%3Darticle%26aulast%3DPinkerton%26date%3D2019%26atitle%3DDiscovery%2Bof%2B%25CE%25B2-Arrestin%2BBiased%252C%2BOrally%2BBioavailable%252C%2Band%2BCNS%2BPenetrant%2BNeurotensin%2BReceptor%2B1%2B%2528NTR1%2529%2BAllosteric%2BModulators%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D17%26spage%3D8357%26epage%3D8363%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291631" title="Modulators">Modulators</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/jmcmar.2019.62.issue-17/20190912/jmcmar.2019.62.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Neurotensin receptor 1 (NTR1) is a G protein coupled receptor that is widely expressed throughout the central nervous system where it acts as a neuromodulator. Neurotensin receptors have been implicated in a wide variety of CNS disorders, but despite extensive efforts to develop small molecule ligands there are few reports of such compounds. Herein we describe the optimization of a quinazoline based lead to give <b>18</b> (SBI-553), a potent and brain penetrant NTR1 allosteric modulator.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The tridecapeptide neurotransmitter neurotensin (NT)<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> is widely distributed throughout the central and peripheral nervous systems,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> where it acts as a neurotransmitter and neuromodulator, in particular for dopamine (DA) signaling.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Neurotensin binds two G-protein-coupled receptors, NTR1 and NTR2,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> and neurotensin has been implicated in numerous CNS disorders such as schizophrenia,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Parkinson’s disease,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and drug addiction.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> NTR1 is the most widely studied, mediates most of the known neurotensin effects, and holds the potential as an interesting therapeutic target.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In addition, two crystal structures of NTR1 have been recently reported.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Despite the therapeutic promise of NTR1, it has proven to be difficult to develop ligands for the receptor. While there have been numerous reports of peptide agonists of NTR1,<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> which in general suffer from poor oral bioavailability and CNS penetration, only a handful of small molecule antagonists and agonists (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) have been described. The most advanced compounds include the nM antagonists from Sanofi SR48692 (Meclinertant),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> which completed PhII clinical trials, and the related analogue SR142948A.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Positive modulators include sub-μM compounds from RTI,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> which was derived from the SR compounds, and the related imidazole ML301.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In addition, a weakly active indole based partial agonist from Wyeth<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and an optimized full agonist analogue from Scripps (SR-12062) have been reported.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> We have reported on a series of β-arrestin biased quinazoline positive modulators of NTR1, exemplified by our probe compound ML314 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> While ML314 was moderately potent, displayed good brain penetration after IP dosing, and was active in vivo in a number of animal models of addiction,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> it displayed low oral bioavailability (<5%). We therefore embarked on an optimization campaign to improve both potency and oral bioavailability. Herein we disclose the discovery of SBI-553, an optimized derivative with a 10-fold potency improvement and significantly improved bioavailability that maintains good CNS penetration.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected previously reported NTR1 ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Quinazoline NTR1 modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82346" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82346" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The compounds described in this paper consist of a quinazoline core structure with an N-linked piperdine or piperazine in the 4 position. The synthesis of most analogues followed our previously described routes<a onclick="showRef(event, 'ref20 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref22">(20,22)</a> (for full synthetic details, see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_001.pdf" class="ext-link">Supporting Information (SI)</a>). A representative synthesis is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Starting from an appropriate substituted carboxylic acid (<b>9</b>), conversion to the acid chloride followed by reaction with a 2-cyanoaniline (<b>11</b>) gave intermediate <b>12</b>. Cyclization under basic conditions gave quinazoline <b>13</b>. The amino side chain <b>14</b> was introduced by a copper catalyzed coupling reaction to give intermediate <b>15</b>, which was methylated using reductive alkylation to give <b>16</b>. <b>16</b> was coupled with the substituted piperdine <b>17</b> to provide the final product <b>18</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Representative Synthesis of Quinazoline Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (COCl)<sub>2</sub>, 35 °C, 1.5 h; (b) pyridine, DCM, rt, 2 h, 86% over 2 steps; (c) NaOH, H<sub>2</sub>O<sub>2</sub>, EtOH, reflux, 12 h, 66%; (d) K<sub>3</sub>PO<sub>4</sub>, CuI, proline, DMSO, 100 °C, 12 h; (e) NaBH(OAc)<sub>3</sub>, HCHO, MeOH, rt, 1 h, 39% over 2 steps; (f) BOP, DBU, CH<sub>3</sub>CN, rt, 12 h, 87%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> SAR</h3><div class="NLM_p">We have previously reported the preliminary SAR around the quinazoline scaffold to give the probe compound <b>7</b>, ML314.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> However, ML314, while selective, displays only moderate potency (∼2.8 μM) and modest pharmacokinetics, with low oral bioavailability (<5%). We therefore embarked on an SAR campaign to improve both of these parameters. For our primary SAR driving assay, we used a high content assay measuring NT receptor mediated β-arrestin redistribution as previously reported.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The primary counterscreen was an assay for NTR2 in the same format. Our initial SAR around the ML314 scaffold investigated a wide range of substituents around the quinazoline ring as well as around the pendant phenyl ring on the piperazine. Of the >100 analogues synthesized (data not shown) only one, the dimethylamine analogue <b>8</b> displayed activity higher than the parent compound (NTR1 EC<sub>50</sub> = 0.71 μM). During the course of our preliminary investigation, we also examined the piperazine linker; only 6-membered rings gave active compounds, and there was strong preference for a nitrogen linkage to the quinazoline core. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, piperdine <b>19b</b> was approximately 3-fold more potent than the piperazine, while <b>19a</b>, with the reverse linkage, was not active.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Structures and NTR1 Activities of Analogues <b>19</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0006.gif" alt="" id="GRAPHIC-d7e472-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b> (ML314)</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">2.87 ± 1.43 (171)</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19a</b></td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">>20</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19b</b></td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">1.04 ± 0.14</td><td class="colsep0 rowsep0" align="center">89</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">β-Arrestin2-GFPNTR1 potency measured relative to the EC<sub>100</sub> (100 nM) of the NT(8–13) peptide control average ± SEM (<i>n</i> = 4 unless otherwise noted).</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last"><i>E</i><sub>max</sub> was calculated as the % of the response obtained with NT(8–13) peptide. None of the compounds from this series showed activity in the NTR2 (>80 μM) counterscreen.</p></div></div></div><div class="NLM_p">With this result in hand, we then re-examined the SAR around the core (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Similar to the results with the piperazine linked compound <b>8</b>, a dimethylamine group in the 6 position (<b>20a</b>) was reasonably potent. Increasing the size to an ethyl group improved activity (<b>20b</b>), although there were no further gains in potency going to the propyl analogue (<b>20d</b>). Similar to previous SAR, the 6 position was preferred, with substitution in the 5 (<b>20c</b>) or 7 (<b>20e</b>) giving substantially less potent analogues. Adding an additional methyl (<b>20f</b>) or fluoro (<b>20g</b>) in the 7 position gave compounds of lower potency. A range of analogues that were substituted with a methoxy (<b>20h</b>), hydroxy (<b>20i</b>), or morpholino (<b>20j</b>) group showed that all modifications were tolerated, with hydroxy compound <b>20i</b> being the most potent. Piperdine (<b>20k</b>,<b>20l</b>) and pyrrolidine (<b>20m</b>–<b>p</b>) substitution also gave compounds that showed good activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structures and NTR1 Activities of Analogues <b>20</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0007.gif" alt="" id="GRAPHIC-d7e649-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0008.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">β-Arrestin2-GFP NTR1 potency measured relative to the EC<sub>100</sub> (100 nM) of the NT(8–13) peptide control average ± SEM (<i>n</i> = 4 unless otherwise noted).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last"><i>E</i><sub>max</sub> was calculated as the % of the response obtained with NT(8–13) peptide. None of the compounds from this series showed activity in the NTR2 (>80 μM) counterscreen.</p></div></div><div></div></div><div class="NLM_p">We then turned to examining the effect of substitution on the cyclopropyl ring off the quinazoline core (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Substitution at the 2 and 3 positions of the cyclopropyl ring were generally poorly tolerated (data not shown); however, substitution at the 1 position was tolerated and also improved the PK properties (vide infra). While in some cases potency was not improved (for example, <b>21a</b> compared to <b>20d</b> or <b>21e</b> to <b>20a</b>), the combination of the hydroxyethyl group with either a fluorine (<b>18</b>, SBI-553) or a methyl group (<b>21e</b>) gave up to a 5-fold increase in potency. Interestingly, the corresponding analogues with either a methoxyethyl (<b>21c</b>,<b>21d</b>) or morpholinoethyl (<b>21g</b>–<b>i</b>) did not show a similar potency boost.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structures and NTR1 Activities of Analogues <b>21</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0009.gif" alt="" id="GRAPHIC-d7e717-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0010.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">β-Arrestin2-GFP NTR1 potency measured relative to the EC<sub>100</sub> (100 nM) of the NT(8–13) peptide control average ± SEM (<i>n</i> = 4 unless otherwise noted).</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last"><i>E</i><sub>max</sub> was calculated as the % of the response obtained with NT(8–13) peptide. None of the compounds from this series showed activity in the NTR2 (>80 μM) counterscreen.</p></div></div><div></div></div><div class="NLM_p">We also investigated a range of other groups in place of the cyclopropyl group (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Cyclobutyl (<b>22a</b>) was well tolerated, but potency dropped off when the ring size was increased to cylcopentyl (<b>22b</b>). A phenyl substituent (<b>22c</b>) was also less active. As with the cyclopropyl compounds <b>18</b> and <b>21e</b>, substitution of the cyclobutyl group in the 1 position with either F (<b>22d</b>) or methyl (<b>22e</b>) gave potent compounds, although activity was not substantially improved in the case of methyl analogue <b>22e</b>, which is in contrast with the corresponding analogue <b>21e</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Structures and NTR1 Activities of Analogues <b>22</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0011.gif" alt="" id="GRAPHIC-d7e782-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0012.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">β-Arrestin2-GFP NTR1 potency measured relative to the EC<sub>100</sub> (100 nM) of the NT(8–13) peptide control average ± SEM (<i>n</i> = 4 unless otherwise noted).</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last"><i>E</i><sub>max</sub> was calculated as the % of the response obtained with NT(8–13) peptide. None of the compounds from this series showed activity in the NTR2 (>80 μM) counterscreen.</p></div></div><div></div></div><div class="NLM_p">Lastly, we examined substitution of the quinoline core as outlined in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>. Compared with the unsubstituted analogue (<b>20i</b>) we observed only modest variations in potency with F, Cl, or methyl substitution, with the 8 position being preferred for substitution (compare <b>23b</b>, <b>23e</b>, and <b>23h</b>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Structures and NTR1 Activities of Analogues <b>23</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0013.gif" alt="" id="GRAPHIC-d7e831-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char="±">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>E</i><sub>max</sub> (%)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23a</b></td><td class="colsep0 rowsep0" align="center">5-F</td><td class="colsep0 rowsep0" align="char" char="±">0.59 ± 0.08 (8)</td><td class="colsep0 rowsep0" align="center">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23b</b></td><td class="colsep0 rowsep0" align="center">8-F</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.04 (8)</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23c</b></td><td class="colsep0 rowsep0" align="center">5-Me</td><td class="colsep0 rowsep0" align="char" char="±">1.26 ± 0.36 (8)</td><td class="colsep0 rowsep0" align="center">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23d</b></td><td class="colsep0 rowsep0" align="center">7-Me</td><td class="colsep0 rowsep0" align="char" char="±">0.56 ± 0.11</td><td class="colsep0 rowsep0" align="center">88</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23e</b></td><td class="colsep0 rowsep0" align="center">8-Me</td><td class="colsep0 rowsep0" align="char" char="±">0.16 ± 0.04 (8)</td><td class="colsep0 rowsep0" align="center">87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23f</b></td><td class="colsep0 rowsep0" align="center">5-Cl</td><td class="colsep0 rowsep0" align="char" char="±">0.50 ± 0.16</td><td class="colsep0 rowsep0" align="center">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23g</b></td><td class="colsep0 rowsep0" align="center">7-Cl</td><td class="colsep0 rowsep0" align="char" char="±">0.60 ± 0.24 (23)</td><td class="colsep0 rowsep0" align="center">98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23h</b></td><td class="colsep0 rowsep0" align="center">8-Cl</td><td class="colsep0 rowsep0" align="char" char="±">0.22 ± 0.14</td><td class="colsep0 rowsep0" align="center">95</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">β-Arrestin2-GFP NTR1 potency measured relative to the EC<sub>100</sub> (100 nM) of the NT(8–13) peptide control average ± SEM (<i>n</i> = 4 unless otherwise noted).</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last"><i>E</i><sub>max</sub> was calculated as the % of the response obtained with NT(8–13) peptide. None of the compounds from this series showed activity in the NTR2 (>80 μM) counterscreen.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmacokinetics</h3><div class="NLM_p">We examined a range of analogues for their rodent PK properties, with the results for the fluoro-cyclopropyl (<b>18</b>, SBI-553) and methyl-cyclopropyl (<b>21e</b>) analogues shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. Both analogues showed high clearance but also a high volume of distribution in both mouse and rat with good oral bioavailability (∼50%) and half-life in both species. In addition, the brain:plasma ratio 1 h post dose was good for SBI-553 in both mouse (0.54) and rat (0.98). Similar brain:plasma ratios in rat were observed 4 and 8 h post dose (PO, data not shown). Because of the combination of potency, bioavailability, and brain penetration, <b>18</b> (SBI-553) was selected for further in vitro and in vivo pharmacological profiling.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Selected Mouse or Rat PK Parameters for <b>18</b> and <b>21e</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">Cl<sub>p</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>(mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Vd<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a>(L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a> (h)</th><th class="colsep0 rowsep0" align="center" char=".">%<i>F</i></th><th class="colsep0 rowsep0" align="center" char=".">brain:plasma @1 h<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b> (SBI-553)</td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">44.8</td><td class="colsep0 rowsep0" align="char" char=".">6.16</td><td class="colsep0 rowsep0" align="char" char=".">1460</td><td class="colsep0 rowsep0" align="char" char=".">4824</td><td class="colsep0 rowsep0" align="char" char=".">5.28</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">0.54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21e</b></td><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">79.4</td><td class="colsep0 rowsep0" align="char" char=".">7.68</td><td class="colsep0 rowsep0" align="char" char=".">627</td><td class="colsep0 rowsep0" align="char" char=".">3324</td><td class="colsep0 rowsep0" align="char" char=".">2.90</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b> (SBI-553)</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">81.0</td><td class="colsep0 rowsep0" align="char" char=".">7.02</td><td class="colsep0 rowsep0" align="char" char=".">3482</td><td class="colsep0 rowsep0" align="char" char=".">2693</td><td class="colsep0 rowsep0" align="char" char=".">2.23</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Compounds dosed 5 mpk iv and 30 mpk po.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">iv.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">po.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> In Vitro Profiling</h3><div class="NLM_p">This series of compounds display a unique profile in that they are allosteric modulators of NTR1 that selectively enhance the interaction with β-arrestin while blocking the classical Ca<sup>2+</sup> signaling. Extensive in vitro and in vivo characterization, including the consequences of this biased signaling, will be reported elsewhere.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Similar to ML314, <b>18</b> (SBI-553) alone showed no activity in a Ca<sup>2+</sup> flux assay.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Also, as observed with ML314, <b>18</b> (SBI-553) appears to act as a positive allosteric modulator of neurotensin peptide binding. <b>18</b> (SBI-553) was evaluated by Eurofins Panlabs Discovery Services<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> in a radioligand binding assay that examined the binding of radiolabeled neurotensin (NT) to membranes prepared from cells overexpressing human NTR1 or NTR2 or mouse NTR. Unlike orthosteric ligands, which displace neurotensin, significant enhancement of neurotensin peptide binding to the human NTR1 and mouse NTR1, but not human NTR2, was observed in the presence of increasing concentrations of <b>18</b> (SBI-553) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), indicating both the selectivity of the compound as well as confirming its unique mechanism of action.</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Augmentation of [<sup>125</sup>I]-NT binding (0.02 nM) to cell membranes in the presence of increasing doses of <b>18</b> (SBI-553). The EC<sub>50</sub> for SBI-553 at the human receptor for this experiment was 0.14 μM, with a maximum efficacy of 140% (data were plotted and analyzed using GraphPad Prism v 7, <i>n</i> = 2). Efficacy is relative to the maximal displacement of orthosteric ligands (i.e., −100%). Data point excluded from curve fitting is shown in red. NT peptide in these assays give <i>K</i><sub>d</sub>s of 0.082 nM (hNTR1), 0.59 nM (hNTR2), and 0.17 nM (mNTR), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The presence of <b>18</b> (SBI-553) had no effect on the potency of NT in the NTR1 high-content (β-arrestin2-GFP) assay (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). EC<sub>50</sub> values for NT in this assay ranged from 0.37 to 0.40 nM across the range of <b>18</b> (SBI-553) doses tested (0.5–356 nM), while the EC<sub>50</sub> for NT in the absence of <b>18</b> (SBI-553) was 0.40 nM. In contrast, the EC<sub>50</sub> for NT in the Ca<sup>2+</sup> flux assay (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B) was shifted to the right over the tested concentration range of <b>18</b> (SBI-553), 0.0088–2.15 μM, but did not quite reach saturation as indicated by the separation of the response curves at higher concentrations. In the absence of <b>18</b> (SBI-553), the EC<sub>50</sub> for NT in this assay was 0.035 nM, while the EC<sub>50</sub> for the NT was shifted >30-fold (1.18 nM) in the presence of 2.15 μM <b>18</b> (SBI-553). A Schild analysis of these results (SI, <a class="ref internalNav" href="#notes1" aria-label="Figure S1">Figure S1</a>) supports the notion that <b>18</b> (SBI-553) acts functionally similar to a competitive antagonist over this range. Thus, from <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, and SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_001.pdf" class="ext-link">Figure S1</a>, <b>18</b> (SBI-553) can be considered a β-arrestin-biased modulator and acts functionally like a “PAM antagonist” of the Ca<sup>2+</sup> pathway with respect to its effects on NT/NTR1 signaling.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose response of NT peptide in the presence of <b>18</b> (SBI-553) in the β-arrestin (A) and Ca<sup>2+</sup> flux (B) assays. Data were plotted and analyzed using GraphPad Prism v 7 and are presented as an average ± SEM (<i>n</i> = 4). The compound shows divergent behavior, with no effect on the EC<sub>50</sub> in the β-arrestin assay but a strong rightward shift in the Ca<sup>2+</sup> flux assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">As with ML314, <b>18</b> (SBI-553) showed no cross reactivity against a range of related and unrelated GPCRs using the same high-content assay format (NTR2, GPR35, GPR55, κ-opioid). <b>18</b> (SBI-553) was also screened in a Eurofins/Panlabs panel of 80 targets and showed moderate promiscuity with binding (>30%) against 10 receptors at 10 μM concentration. Subsequent dose titrations indicated binding at the adrenergic α<sub>2a</sub> (55% at 5 μM), dopamine D<sub>1</sub> (36% at 5 μM), histamine H<sub>1</sub> (75% at 5 μM), and 5-HT<sub>2B</sub> (42% at 5 μM) receptors.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> In Vivo Efficacy</h3><div class="NLM_p">We then examined the effect of <b>18</b> (SBI-553) in vivo, after both IP (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B) and PO (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C,D) in the dopamine transporter knockout mouse model model of hyperdopaminergic activity.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Unlike the peptide NTR1 agonist PD149163, which causes significant hypotension and hypothermia, animals dosed with <b>18</b> did not show any adverse effects. In addition, <b>18</b> attenuated hyperlocomotion after both IP and PO dosing. Full in vivo profiling of <b>18</b> will be reported elsewhere.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0017.jpeg" id="GRAPHIC-d7e1551-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>18</b> (SBI-553) attenuates basal hyperlocomotion in dopamine transporter knockout (DAT<sup>–/–</sup>) mice. Locomotor activity was evaluated using open field automated activity monitors (AccuScan Instruments, Columbus, OH). Male and female DAT<sup>–/–</sup> mice were acclimated to the open field chamber for 30 min prior to administration of NTR1 ligands (indicated by arrow). After treatment, animals were immediately returned to chambers and horizontal locomotion was monitored over the next 2 h. (A) Animals received SBI-553 (12 mg/kg), PD149163 (1 mg/kg), or vehicle (4% DMSO in saline; 10 mL/kg) ip. Beam breaks in 5 min intervals were recorded to generate horizontal distance traveled per time bin. *<i>p</i> < 0.05, <i>p</i> < 0.001 Vehicle vs SBI-553; #<i>p</i> < 0.05, <i>p</i> < 0.001 Vehicle vs PD149163; ∼<i>p</i> < 0.05, <i>p</i> < 0.001 SBI-553 vs PD149163, using a two-way, repeated measures ANOVA (<i>F</i><sub>Time</sub>(23,1679) = 13.5, <i>p</i> < 0.0001; <i>F</i><sub>Treatment</sub>(2,73) = 45.1, <i>p</i> < 0.0001; <i>F</i><sub>Interaction</sub>(46,1679) = 10.4, <i>p</i> < 0.0001) followed by the post hoc Tukey test. (B) Time course data in (A) was summed to determine the total distance traveled in the 2 h post-treatment. ***, ###, ∼∼∼ <i>p</i> < 0.001, as indicated, using one-way ANOVA (<i>F</i>(2,72) = 46.6, <i>p</i> < 0.0001) followed by the post hoc Tukey test. Data are represented as mean ± SEM of 18–29 animals per group. (C) Animals received SBI-553 10, 30, or 100 mg/kg or vehicle (distilled H<sub>2</sub>O) po. Beam breaks in 5 min intervals were recorded to generate horizontal distance traveled per time bin. *<i>p</i> < 0.05, <i>p</i> < 0.001 Vehicle vs 100 mg/kg SBI-553; #<i>p</i> < 0.05 Vehicle vs 30 mg/kg SBI-553; ∼<i>p</i> < 0.05 10 mg/kg SBI-553 vs 100 mg/kg SBI-553, using a two-way, repeated measures ANOVA (<i>F</i><sub>Time</sub>(23,989) = 8.6, <i>p</i> < 0.0001; <i>F</i><sub>Treatment</sub>(3,43) = 6.8, <i>p</i> < 0.001; <i>F</i><sub>Interaction</sub>(69,989) = 1.1, <i>p</i> = 0.2726) followed by the post hoc Tukey test. (D) Time course data in (C) was summed to determine the total distance traveled in the 2 h post-treatment. **<i>p</i> < 0.01, #<i>p</i> < 0.05, ∼<i>p</i> < 0.05, as indicated, using one-way ANOVA (<i>F</i>(3,43) = 6.8, <i>p</i> < 0.001) followed by the post hoc Tukey test. Data are represented as mean ± SEM of 11–12 animals per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we have optimized a series of quinazoline based NTR1 modulators to give a potent and orally available compound. In the process, we have maintained a unique mechanism of action wherein the compound enables biased β-arrestin interactions and acts as an antagonist on the Ca<sup>2+</sup> pathway for Gq mediated activation. An extensive account of the implications and benefits of this biased signaling in vitro and in vivo, including important differences in their toxicity profiles relative to standard neurotensin ligands<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and a structural basis<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> for their mechanism of action will be published elsewhere.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds were purified to >95% as determined by LC/MS as well as <sup>1</sup>H (and <sup>13</sup>C in select cases) NMR and HRMS. The analytical methods, general chemistry, experimental information, and syntheses of all other compounds are supplied in the <a class="ref internalNav" href="#notes1" aria-label="Supporting Information">Supporting Information</a>.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Synthesis of 2-({2-(1-Fluoro-cyclopropyl)-4-[4-(2-methoxy-phenyl)-piperidin-1-yl]-quinazolin-6-yl}-methylamino)-ethanol (<b>18</b>)</h3><div class="NLM_p last">Steps a,b: To a solution of 1-fluoro-cyclopropanecarboxylic acid (Oakwood Products, West Columbia, SC, <b>9</b>, 50.8 g, 0.49 mol) in methylene chloride (500 mL), was added oxalyl dichloride (74.7 g, 0.59 mol) and DMF (0.5 mL). The mixture was stirred at 35 °C for 1.5 h. The resulting solution was added slowly to a solution of 2-amino-5-bromo-benzonitrile (Sigma-Aldrich, St. Louis, MO, <b>11</b>, 96 g, 0.49 mol) in methylene chloride (1 L) and pyridine (300 mL). The reaction was stirred at room temperature for 2 h, then was washed with water (1 L), 1 N HCl (1 L), and saturated NaHCO<sub>3</sub> solution (1 L), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated, and the residue was triturated with MeOH to give 1-fluoro-cyclopropanecarboxylic acid (4-bromo-2-cyano-phenyl)-amide (<b>12</b>, 78 g).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The mother liquid was concentrated and purified by silica gel column (petroleum ether/ethyl acetate = 10/1) to give additional 1-fluoro-cyclopropanecarboxylic acid (4-bromo-2-cyano-phenyl)-amide (<b>12</b>, 41 g, total yield 86%) as a white solid. Step c: To a suspension of 1-fluoro-cyclopropanecarboxylic acid (4-bromo-2-cyano-phenyl)-amide (<b>12</b>, 78 g, 276 mmol) in EtOH (1.6 L) and H<sub>2</sub>O<sub>2</sub> (30%, 300 mL), was added NaOH (13.23 g, 0.33 mol). The mixture was stirred at 85 °C overnight. The reaction was worked up together with another batch (using 1-fluoro-cyclopropanecarboxylic acid (4-bromo-2-cyano-phenyl)-amide (<b>12</b>, 41 g, 145 mmol), EtOH, 850 mL, H<sub>2</sub>O<sub>2</sub> (30%, 150 mL), and NaOH (7 g, 0.17 mol)). The combined reaction solution was concentrated to 800 mL and poured into cold water (1.2 L). The precipitate was collected by filtration to give 6-bromo-2-(1-fluoro-cyclopropyl)-quinazolin-4-ol (<b>13</b>, 39 g).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The filtrate was treated with excess Na<sub>2</sub>SO<sub>4</sub> and extracted with ethyl acetate (0.6 L × 2). The organic layer was concentrated to 200 mL and filtered to remove Na<sub>2</sub>SO<sub>4</sub>. The filtrate was taken up with ethyl acetate (100 mL) and stored at room temperature for 2 days. The solid that was formed was collected by filtration, the cake was washed with H<sub>2</sub>O, and dried to give 6-bromo-2-(1-fluoro-cyclopropyl)-quinazolin-4-ol (<b>13</b>, 40 g of recrystallized product, total of 79 g, total yield: 66%)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> as a light-yellow solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 12.71 (brs, 1H), 8.17 (d, <i>J</i> = 2.4 Hz, 1H), 7.92 (dd, <i>J</i> = 8.7, 2.1 Hz, 1H), 7.52 (d, <i>J</i> = 8.7 Hz, 1H), 1.60–1.48 (m, 4H). Steps d,e: A mixture of 6-bromo-2-(1-fluoro-cyclopropyl)-quinazolin-4-ol (<b>13</b>, 67 g, 237 mmol), 2-amino-ethanol (<b>14</b>, 21.6 g, 355 mmol), CuI (4.5 g, 23.7 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.73 g, 23.7 mmol), and K<sub>3</sub>PO<sub>4</sub> (100 g, 474 mmol) in DMSO was stirred at 100 °C under N<sub>2</sub> overnight. The reaction was concentrated to give crude 2-(1-fluoro-cyclopropyl)-6-(2-hydroxy-ethylamino)-quinazolin-4-ol (<b>15</b>). The crude material was dissolved in MeOH (800 mL) and water (400 mL). To the mixture was added formaldehyde solution (37%, 45 g), NaBH(AcO)<sub>3</sub> (59 g, 280 mmol), and NaBH<sub>3</sub>CN (27 g, 420 mmol). The reaction was stirred at room temperature for 1 h. The solution was poured into water (3 L) and extracted with ethyl acetate (1.5 L × 3). The organic layers were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified by silica gel column (methylene chloride/MeOH = 20/1) to give 2-(1-fluoro-cyclopropyl)-6-[(2-hydroxy-ethyl)-methylamino]-quinazolin-4-ol (<b>16</b>, 32 g, yield 39% over 2 steps)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 12.25 (brs, 1H), 7.43 (d, <i>J</i> = 9.2 Hz, 1H), 7.28 (dd, <i>J</i> = 9.2, 3.2 Hz, 1H), 7.17 (d, <i>J</i> = 2.8 Hz, 1H), 4.75 (brs, 1H), 3.57–3.47 (m, 4H), 3.01 (s, 3H), 1.52–1.36 (m, 4H). Step f: To a suspension of 2-(1-fluoro-cyclopropyl)-6-[(2-hydroxy-ethyl)-methylamino]-quinazolin-4-ol (<b>16</b>, 14.2 g, 51.3 mmol) and BOP (34 g, 77 mmol) in MeCN (500 mL) was added DBU (31.2 g, 205 mmol), and the mixture was stirred for 5 min. To the reaction, 4-(2-methoxy-phenyl)-piperidine (<b>17</b>, HCl salt, 12.8 g, 56.4 mmol) was added. The reaction was stirred at room temperature overnight and filtered. The filter cake was washed with MeCN (100 mL) and dried to give 2-({2-(1-fluoro-cyclopropyl)-4-[4-(2-methoxy-phenyl)-piperidin-1-yl]-quinazolin-6-yl}-methylamino)-ethanol (<b>18</b>, 20 g, yield 87%) as a yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.98 (d, <i>J</i> = 9.2 Hz, 1H), 7.41 (dd, <i>J</i> = 9.3, 2.6 Hz, 1H), 7.24 (t, <i>J</i> = 7.4 Hz, 2H), 6.99 (t, <i>J</i> = 7.9 Hz, 2H), 6.91 (d, <i>J</i> = 8.2 Hz, 1H), 4.42 (d, <i>J</i> = 13.2 Hz, 2H), 3.90 (t, <i>J</i> = 5.7 Hz, 2H), 3.87 (s, 3H), 3.60 (t, <i>J</i> = 5.6 Hz, 2H), 3.36–3.27 (m, 1H), 3.19 (t, <i>J</i> = 12.6 Hz, 2H), 3.08 (s, 3H), 2.30 (broad s, 1H), 2.00 (d, <i>J</i> = 12.8 Hz, 2H), 1.95–1.85 (m, 2H), 1.59–1.50 (m, 4H). <sup>13</sup>C NMR (126 MHz, CDCl<sub>3</sub>) δ 164.33 (d, <i>J</i><sub>C–F</sub>= 3.6 Hz), 159.17 (d, <i>J</i><sub>C–F</sub> = 20.3 Hz), 156.80, 146.99, 144.97, 133.65, 129.07, 127.17, 126.48, 121.63, 120.65, 116.49, 110.41, 103.79, 79.01 (d, <i>J</i><sub>C–F</sub> = 218.0 Hz), 60.08, 55.47, 55.30, 50.51, 38.95, 35.74, 31.81, 15.00 (d, <i>J</i><sub>C–F</sub> = 10.8 Hz). HRMS: calculated for C<sub>26</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>2</sub>: <i>m</i>/<i>z</i> = 451.2509; (M + H<sup>+</sup>) and observed <i>m</i>/<i>z</i> = 451.2528. HPLC purity: 99%.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> In Vivo Studies</h3><div class="NLM_p last">PD149163 was purchased from MilliporeSigma (St. Louis, MO). All compounds were freshly prepared in indicated vehicles on the day of testing.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Animals</h3><div class="NLM_p last">Experiments employed adult male and female DAT KO mice<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> maintained on a C57BL/6J background. Animals within studies were 12–24 week old, 18–30 g body weight, and were age- and sex-matched. Animals were maintained on a 12/12 h light/dark cycle and supplied tap water and standard laboratory chow ad libitum except during testing. Mice were randomly assigned to treatment groups, and all experiments were carried out at the beginning of the light cycle. All mouse studies were conducted in accordance with the National Institutes of Health Guidelines for Animal Care and Use and with approved animal protocols from the Duke University Animal Care and Use Committee.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Locomotor Activity</h3><div class="NLM_p last">Locomotor activity was evaluated by open field automated activity monitors (AccuScan Instruments, Columbus, OH) featured with eight photobeams equally distributed along the border, as previously described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> To assess the effect of NTR1 ligands on the basal hyperlocomotion exhibited by DAT KO animals, adult male and female DAT KO mice were acclimated to the open field for 30 min prior to treatment. For ip dosing studies, treatments included 12 mg/kg SBI-553, 1 mg/kg PD149163, or vehicle (4% DMSO in saline) delivered in a 10 mL/kg volume. For po dosing studies, treatments included 10, 30, or 100 mg/kg SBI-553 as the HCl salt or vehicle (distilled H<sub>2</sub>O) delivered in a 10 mL/kg volume. Prior to oral dosing studies animals were habituated to oral dosing via 5 consecutive daily sessions in which 10 mL/kg H<sub>2</sub>O was delivered po. After treatment on test days, animals were immediately returned to activity monitors and locomotor activity was recorded over the next 2 h. Infrared beam breaks in 5 min intervals were recorded to generate horizontal distance traveled per time bin. Distance values were averaged across mice, and the means ± SEM were plotted. Total distance traveled in the 2 h post-treatment was calculated by summing the time bins between 30 and 150 min. Data were plotted and analyzed using GraphPad Prism V.7.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00340" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11667" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11667" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00340" class="ext-link">10.1021/acs.jmedchem.9b00340</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures and spectroscopic data for selected compounds, details of the PK studies, and assay protocols for the binding studies. (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_001.pdf">jm9b00340_si_001.pdf (5.2 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_002.csv">jm9b00340_si_002.csv (3.53 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00340" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48265" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48265" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony B. Pinkerton</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4571-152X" title="Orcid link">http://orcid.org/0000-0003-4571-152X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f495849d9a9f9186809b9ab4879684909d87979b8291868dda9b8693"><span class="__cf_email__" data-cfemail="afcedfc6c1c4cadddbc0c1efdccddfcbc6dcccc0d9caddd681c0ddc8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Satyamaheshwar Peddibhotla</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fusayo Yamamoto</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lauren M. Slosky</span> - <span class="hlFld-Affiliation affiliation">Duke
University Medical Center, Durham, North Carolina 27709, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9471-9117" title="Orcid link">http://orcid.org/0000-0002-9471-9117</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yushi Bai</span> - <span class="hlFld-Affiliation affiliation">Duke
University Medical Center, Durham, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick Maloney</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Hershberger</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael P. Hedrick</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bekhi Falter</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert J. Ardecky</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Layton H. Smith</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas D. Y. Chung</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael R. Jackson</span> - <span class="hlFld-Affiliation affiliation">Conrad
Prebys Center for Chemical Genomics, Sanford
Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc G. Caron</span> - <span class="hlFld-Affiliation affiliation">Duke
University Medical Center, Durham, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence S. Barak</span> - <span class="hlFld-Affiliation affiliation">Duke
University Medical Center, Durham, North Carolina 27709, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9170-2141" title="Orcid link">http://orcid.org/0000-0002-9170-2141</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>This work represents a collaborative effort from Sanford Burnham Prebys Medical Discovery Institute (SBP) and Duke University led by senior investigators from both institutions (A.B.P., L.S.B., M.G.C.). Investigators at SBP were primarily responsible for SAR studies and investigators at Duke were primarily responsible for in vivo studies. All authors participated in preparing the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): Patent applications covering SBI-553 and related derivatives have been filed by SBP and Duke University.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30478" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30478" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by National Institutes of Health grants R21/33 DA038019 to A.B.P. and 5P30DA029925 to M.G.C. and L.S.B. We acknowledge Peter Wilson at Almac, Craigavon, United Kingdom, for scale up work on <b>18</b>, WuXi, Shanghai, China, for measurements of the PK parameters, Eurofins, Taipei, Taiwan, for the binding studies in Figure 3, and Alexander Braddock and Emmanuel Theodorakis at the University of California, San Diego, for assistance with measuring optical rotations.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NT</td><td class="NLM_def"><p class="first last">neurotensin</p></td></tr><tr><td class="NLM_term">NTR1</td><td class="NLM_def"><p class="first last">neurotensin receptor 1</p></td></tr><tr><td class="NLM_term">NTR2</td><td class="NLM_def"><p class="first last">neurotensin receptor 2</p></td></tr><tr><td class="NLM_term">DA</td><td class="NLM_def"><p class="first last">dopamine</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">GFP</td><td class="NLM_def"><p class="first last">green fluorescent protein</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">BOP</td><td class="NLM_def"><p class="first last">benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicyclo[5.4.0]undec-7-ene</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeman, S. E.</span></span> <span> </span><span class="NLM_article-title">The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>248</i></span>,  <span class="NLM_fpage">6854</span>– <span class="NLM_lpage">6861</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=4745447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaE2cXps1U%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1973&pages=6854-6861&author=R.+Carrawayauthor=S.+E.+Leeman&title=The+isolation+of+a+new+hypotensive+peptide%2C+neurotensin%2C+from+bovine+hypothalami"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami</span></div><div class="casAuthors">Carraway, Robert; Leeman, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6854-61</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A hypotensive peptide, designated neurotensin, was isolated in pure form from acid-Me2CO exts. of bovine hypothalami by column chromatog. and paper electrophoresis.  Amino acid anal. of material recovered after paper electrophoresis at pH 3.5, 6.5, and 8.9 and chromatog. anal. of the dansylated material indicated that the peptide isolated by this procedure was homogenous.  Its amino acid compn. and apparent mol. wt. estd. by chromatog. on Sephadex G-25 indicated that neurotensin is a tridecapeptide composed of Lys, Arg2, Asx, Glx2, Pro2, Ileu, Leu2, Tyr2.  Neurotensin lacks a free N-terminus; however, it possesses a free C-terminus which can be acted upon by carboxypeptidase A.  Neurotensin induced hypotension in the rat and stimulated the contraction of guinea pig ileum and rat uterus; however, it produced relaxation of the rat duodenum.  These pharmacol. properties classify it as a kinin, yet its chem. compn. distinguishes it from any known peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGUMbGcmJyBrVg90H21EOLACvtfcHk0ljp5gQ_cK-tEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXps1U%253D&md5=717f2fac48338b8403ea764e6e59db00</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarraway%26aufirst%3DR.%26aulast%3DLeeman%26aufirst%3DS.%2BE.%26atitle%3DThe%2520isolation%2520of%2520a%2520new%2520hypotensive%2520peptide%252C%2520neurotensin%252C%2520from%2520bovine%2520hypothalami%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1973%26volume%3D248%26spage%3D6854%26epage%3D6861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uhl, G. R.</span></span> <span> </span><span class="NLM_article-title">Distribution of neurotensin and its receptor in the central nervous system</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.1982.tb31565.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1111%2Fj.1749-6632.1982.tb31565.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=6301323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A280%3ADyaL3s7ns1KnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1982&pages=132-149&author=G.+R.+Uhl&title=Distribution+of+neurotensin+and+its+receptor+in+the+central+nervous+system&doi=10.1111%2Fj.1749-6632.1982.tb31565.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of neurotensin and its receptor in the central nervous system</span></div><div class="casAuthors">Uhl G R</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-49</span>
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTmvbmgdMnjrYtC3U5jeOifW6udTcc2eYZ2kUZHxqjRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7ns1KnsA%253D%253D&md5=9b488a4ef90d9d0f57c2e6d8f091eb39</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1982.tb31565.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1982.tb31565.x%26sid%3Dliteratum%253Aachs%26aulast%3DUhl%26aufirst%3DG.%2BR.%26atitle%3DDistribution%2520of%2520neurotensin%2520and%2520its%2520receptor%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1982%26volume%3D400%26spage%3D132%26epage%3D149%26doi%3D10.1111%2Fj.1749-6632.1982.tb31565.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quirion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapchak, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A.</span></span> <span> </span><span class="NLM_article-title">Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>668</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.1992.tb27343.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1111%2Fj.1749-6632.1992.tb27343.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1361109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFOjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=668&publication_year=1992&pages=109-119&author=R.+Quirionauthor=W.+B.+Roweauthor=P.+A.+Lapchakauthor=D.+M.+Araujoauthor=A.+Beaudet&title=Distribution+of+neurotensin+receptors+in+mammalian+brain.+What+it+is+telling+us+about+its+interactions+with+other+neurotransmitter+systems&doi=10.1111%2Fj.1749-6632.1992.tb27343.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of neurotensin receptors in mammalian brain.  What it is telling us about its interactions with other neurotransmitter systems</span></div><div class="casAuthors">Quirion, Remi; Rowe, Wayne B.; Lapchak, Paul A.; Araujo, Dalia M.; Beaudet, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">668</span>
        (<span class="NLM_cas:issue">Neurobiol. Neurotensin</span>),
    <span class="NLM_cas:pages">109-19</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    </div><div class="casAbstract">The localization of neurotensin receptors in the central nervous system is described.  Evidence is presented showing that neurotensin, by acting on specific receptors, modulates the activity of cholinergic and CRF-contg. neurons, besides dopaminergic neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqqjoqGereWbVg90H21EOLACvtfcHk0lh3_lAgmG7mxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFOjs7Y%253D&md5=86461b6824d933da61e6d23fc20e63c0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1992.tb27343.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1992.tb27343.x%26sid%3Dliteratum%253Aachs%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DRowe%26aufirst%3DW.%2BB.%26aulast%3DLapchak%26aufirst%3DP.%2BA.%26aulast%3DAraujo%26aufirst%3DD.%2BM.%26aulast%3DBeaudet%26aufirst%3DA.%26atitle%3DDistribution%2520of%2520neurotensin%2520receptors%2520in%2520mammalian%2520brain.%2520What%2520it%2520is%2520telling%2520us%2520about%2520its%2520interactions%2520with%2520other%2520neurotransmitter%2520systems%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1992%26volume%3D668%26spage%3D109%26epage%3D119%26doi%3D10.1111%2Fj.1749-6632.1992.tb27343.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and neurotensin receptors</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1016/S0165-6147(99)01357-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2FS0165-6147%2899%2901357-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10390649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK1MXntlOmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=302-309&author=J.-P.+Vincentauthor=J.+Mazellaauthor=P.+Kitabgi&title=Neurotensin+and+neurotensin+receptors&doi=10.1016%2FS0165-6147%2899%2901357-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin and neurotensin receptors</span></div><div class="casAuthors">Vincent, Jean-Pierre; Mazella, Jean; Kitabgi, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">302-309</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 67 refs.  Neurotensin is a brain and gastrointestinal peptide that fulfills many central and peripheral functions through its interaction with specific receptors.  Three subtypes of neurotensin receptors have been cloned.  Two of them belong to the family of G protein-coupled receptors, whereas the third one is an entirely new type of neuropeptide receptor and is identical to gp95/sortilin, a 100-kDa-protein with a single transmembrane domain.  In this review, the present knowledge regarding the mol. and pharmacol. properties of the three cloned neurotensin receptors is summarized and the relationship between these receptors and the known pharmacol. effects of neurotensin is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrCeY98U7pkbVg90H21EOLACvtfcHk0lh3_lAgmG7mxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlOmsL8%253D&md5=b188fdab36656f4d2205fd411f0dc9fb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2899%2901357-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252899%252901357-7%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DJ.-P.%26aulast%3DMazella%26aufirst%3DJ.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DNeurotensin%2520and%2520neurotensin%2520receptors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1999%26volume%3D20%26spage%3D302%26epage%3D309%26doi%3D10.1016%2FS0165-6147%2899%2901357-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloteaux, J. M.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Regulation of Neurotensin Receptors</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/S0163-7258(98)00009-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2FS0163-7258%2898%2900009-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=9749878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK1cXltVOktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1998&pages=89-104&author=E.+Hermansauthor=J.+M.+Maloteaux&title=Mechanisms+of+Regulation+of+Neurotensin+Receptors&doi=10.1016%2FS0163-7258%2898%2900009-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of regulation of neurotensin receptors</span></div><div class="casAuthors">Hermans, Emmanuel; Maloteaux, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-104</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with ∼150 refs.  Since its discovery in 1973, the neuropeptide neurotensin has been demonstrated to be involved in the control of a broad variety of physiol. activities in both the central nervous system and in the periphery.  Pharmacol. studies have shown that the biol. effects elicited by neurotensin result from its specific binding to cell membrane neurotensin receptors that have been characterized in various tissue and in cell prepns.  In addn., it is now well documented that most of these responses are subject to rapid desensitization.  Such desensitization results in transient responses to sustained peptide applications, or to tachyphylaxis during successive stimulations in the same conditions.  More recently, desensitization of neurotensin signaling was investigated at the cellular and mol. levels.  In cultured cells, regulation at the second messenger level, receptor internalization, and receptor down-regulation processes have been reported.  These are proposed to play a crit. role in the control of cell responsiveness to neurotensin.  This review aims to compile recent data on the different biochem. processes involved in the regulation of the neurotensin receptor and to discuss the physiol. consequences of this regulation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6GuGi4jfnrbVg90H21EOLACvtfcHk0lh3_lAgmG7mxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltVOktrk%253D&md5=6b4e8c1c60e32b0fd8fe8161f77bed39</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900009-6%26sid%3Dliteratum%253Aachs%26aulast%3DHermans%26aufirst%3DE.%26aulast%3DMaloteaux%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520Regulation%2520of%2520Neurotensin%2520Receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D1998%26volume%3D79%26spage%3D89%26epage%3D104%26doi%3D10.1016%2FS0163-7258%2898%2900009-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nemeroff, C. B.</span></span> <span> </span><span class="NLM_article-title">The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia</span>. <i>Psychoneuroendocrinology</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/0306-4530(86)90029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2F0306-4530%2886%2990029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=2871577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaL28XitVClu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1986&pages=15-37&author=C.+B.+Nemeroff&title=The+interaction+of+neurotensin+with+dopaminergic+pathways+in+the+central+nervous+system%3A+basic+neurobiology+and+implications+for+the+pathogenesis+and+treatment+of+schizophrenia&doi=10.1016%2F0306-4530%2886%2990029-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction of neurotensin with dopaminergic pathways in the central nervous system:  basic neurobiology and implications for the pathogenesis and treatment of schizophrenia</span></div><div class="casAuthors">Nemeroff, Charles B.</div><div class="citationInfo"><span class="NLM_cas:title">Psychoneuroendocrinology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-37</span>CODEN:
                <span class="NLM_cas:coden">PSYCDE</span>;
        ISSN:<span class="NLM_cas:issn">0306-4530</span>.
    </div><div class="casAbstract">A review with 98 refs.  The neurochem., neuroanatomical, and behavioral evidence that have led to the hypothesis that neurotensin is an important endogenous modulator of the activity of dopaminergic systems in the mammalian central nervous system is presented.  The implications of the hypothesis for the etiol., pathogenesis, and treatment of major psychotic disorders, esp. schizophrenia is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp10XNHTSZn7rVg90H21EOLACvtfcHk0lh3_lAgmG7mxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XitVClu74%253D&md5=ec76d824e3090274c9d126bc3463cd5c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0306-4530%2886%2990029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-4530%252886%252990029-6%26sid%3Dliteratum%253Aachs%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DThe%2520interaction%2520of%2520neurotensin%2520with%2520dopaminergic%2520pathways%2520in%2520the%2520central%2520nervous%2520system%253A%2520basic%2520neurobiology%2520and%2520implications%2520for%2520the%2520pathogenesis%2520and%2520treatment%2520of%2520schizophrenia%26jtitle%3DPsychoneuroendocrinology%26date%3D1986%26volume%3D11%26spage%3D15%26epage%3D37%26doi%3D10.1016%2F0306-4530%2886%2990029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schimpff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenelon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lhiaubet, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenneze, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidailhet, M.</span></span> <span> </span><span class="NLM_article-title">Increased plasma neurotensin concentrations in patients with Parkinson’s disease</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1136/jnnp.70.6.784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1136%2Fjnnp.70.6.784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=11385014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A280%3ADC%252BD3Mzht1Sjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=784-786&author=R.+M.+Schimpffauthor=C.+Avardauthor=G.+Fenelonauthor=A.+M.+Lhiaubetauthor=L.+Tennezeauthor=M.+Vidailhet&title=Increased+plasma+neurotensin+concentrations+in+patients+with+Parkinson%E2%80%99s+disease&doi=10.1136%2Fjnnp.70.6.784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Increased plasma neurotensin concentrations in patients with Parkinson's disease</span></div><div class="casAuthors">Schimpff R M; Avard C; Fenelon G; Lhiaubet A M; Tenneze L; Vidailhet M; Rostene W</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">784-6</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">Plasma neurotensin (NT) was measured by radioimmunoassay in propanol extracted and unextracted plasma from 16 parkinsonian patients (four before treatment) and 16 age and sex matched controls.  Mean plasma NT concentrations were consistently higher in parkinsonian patients than in controls and higher in the four untreated patients than in levodopa treated patients suggesting that plasma NT measurement may represent an easy detectable additional index in diagnosing parkinsonism and provides a novel approach to research in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfKosPxJtsNDUE-swuRqsHfW6udTcc2eY2hTV7bETL1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3Mzht1Sjtg%253D%253D&md5=ffe531137c2f920daa88b39e7779b190</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.70.6.784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.70.6.784%26sid%3Dliteratum%253Aachs%26aulast%3DSchimpff%26aufirst%3DR.%2BM.%26aulast%3DAvard%26aufirst%3DC.%26aulast%3DFenelon%26aufirst%3DG.%26aulast%3DLhiaubet%26aufirst%3DA.%2BM.%26aulast%3DTenneze%26aufirst%3DL.%26aulast%3DVidailhet%26aufirst%3DM.%26atitle%3DIncreased%2520plasma%2520neurotensin%2520concentrations%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2001%26volume%3D70%26spage%3D784%26epage%3D786%26doi%3D10.1136%2Fjnnp.70.6.784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredrickson, P.</span></span> <span> </span><span class="NLM_article-title">Neurotensin agonists: possible drugs for treatment of psychostimulant abuse</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1016/S0024-3205(03)00388-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2FS0024-3205%2803%2900388-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=12801589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVehtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=679-690&author=E.+Richelsonauthor=M.+Boulesauthor=P.+Fredrickson&title=Neurotensin+agonists%3A+possible+drugs+for+treatment+of+psychostimulant+abuse&doi=10.1016%2FS0024-3205%2803%2900388-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin agonists: possible drugs for treatment of psychostimulant abuse</span></div><div class="casAuthors">Richelson, Elliott; Boules, Mona; Fredrickson, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">679-690</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Although many neuropeptides have been implicated in the pathophysiol. of psychostimulant abuse, the tridecapeptide neurotensin holds a prominent position in this field due to the compelling literature on this peptide and psychostimulants.  These data strongly support the hypothesis that a neurotensin agonist will be clin. useful to treat the abuse of psychostimulants, including nicotine.  This paper reviews the evidence for a role for neurotensin in stimulant abuse and for a neurotensin agonist for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EiJ-scKBwrVg90H21EOLACvtfcHk0lg6sR8ZJgPn7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVehtL4%253D&md5=4f034616a14545612ed509dd670bec7a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2803%2900388-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252803%252900388-6%26sid%3Dliteratum%253Aachs%26aulast%3DRichelson%26aufirst%3DE.%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DFredrickson%26aufirst%3DP.%26atitle%3DNeurotensin%2520agonists%253A%2520possible%2520drugs%2520for%2520treatment%2520of%2520psychostimulant%2520abuse%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D73%26spage%3D679%26epage%3D690%26doi%3D10.1016%2FS0024-3205%2803%2900388-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredrickson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Diverse Roles of Neurotensin Agonists in the Central Nervous System Front</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">36</span>, <span class="refDoi"> DOI: 10.3389/fendo.2013.00036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.3389%2Ffendo.2013.00036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=23526754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A280%3ADC%252BC3svptlGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=36&author=M.+Boulesauthor=Z.+Liauthor=K.+Smithauthor=P.+Fredricksonauthor=E.+Richelson&title=Diverse+Roles+of+Neurotensin+Agonists+in+the+Central+Nervous+System+Front&doi=10.3389%2Ffendo.2013.00036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse roles of neurotensin agonists in the central nervous system</span></div><div class="casAuthors">Boules Mona; Li Zhimin; Smith Kristin; Fredrickson Paul; Richelson Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">Neurotensin (NT) is a tridecapeptide that is found in the central nervous system (CNS) and the gastrointestinal tract.  NT behaves as a neurotransmitter in the brain and as a hormone in the gut.  Additionally, NT acts as a neuromodulator to several neurotransmitter systems including dopaminergic, sertonergic, GABAergic, glutamatergic, and cholinergic systems.  Due to its association with such a wide variety of neurotransmitters, NT has been implicated in the pathophysiology of several CNS disorders such as schizophrenia, drug abuse, Parkinson's disease (PD), pain, central control of blood pressure, eating disorders, as well as, cancer and inflammation.  The present review will focus on the role that NT and its analogs play in schizophrenia, endocrine function, pain, psychostimulant abuse, and PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRFnBUpHYR8fIW7hznt0zpfW6udTcc2eY2hTV7bETL1bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svptlGisw%253D%253D&md5=1d8b45188dddd238b0783c9564fffd16</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2013.00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2013.00036%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DFredrickson%26aufirst%3DP.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DDiverse%2520Roles%2520of%2520Neurotensin%2520Agonists%2520in%2520the%2520Central%2520Nervous%2520System%2520Front%26jtitle%3DFront.%2520Endocrinol.%26date%3D2013%26volume%3D4%26spage%3D36%26doi%3D10.3389%2Ffendo.2013.00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noinaj, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gvozdenovic-Jeremic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisshammer, R.</span></span> <span> </span><span class="NLM_article-title">Structure of the agonist-bound neurotensin receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>490</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1038/nature11558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1038%2Fnature11558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=23051748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVykt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2012&pages=508-513&author=J.+F.+Whiteauthor=N.+Noinajauthor=Y.+Shibataauthor=J.+Loveauthor=B.+Klossauthor=F.+Xuauthor=J.+Gvozdenovic-Jeremicauthor=P.+Shahauthor=J.+Shiloachauthor=C.+G.+Tateauthor=R.+Grisshammer&title=Structure+of+the+agonist-bound+neurotensin+receptor&doi=10.1038%2Fnature11558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the agonist-bound neurotensin receptor</span></div><div class="casAuthors">White, Jim F.; Noinaj, Nicholas; Shibata, Yoko; Love, James; Kloss, Brian; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Shiloach, Joseph; Tate, Christopher G.; Grisshammer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">490</span>
        (<span class="NLM_cas:issue">7421</span>),
    <span class="NLM_cas:pages">508-513</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neurotensin (NTS) is a 13-amino-acid peptide that functions as both a neurotransmitter and a hormone through the activation of the neurotensin receptor NTSR1, a G-protein-coupled receptor (GPCR).  In the brain, NTS modulates the activity of dopaminergic systems, opioid-independent analgesia, and the inhibition of food intake; in the gut, NTS regulates a range of digestive processes.  Here we present the structure at 2.8 Å resoln. of Rattus norvegicus NTSR1 in an active-like state, bound to NTS8-13, the carboxy-terminal portion of NTS responsible for agonist-induced activation of the receptor.  The peptide agonist binds to NTSR1 in an extended conformation nearly perpendicular to the membrane plane, with the C terminus oriented towards the receptor core.  Our findings provide, to our knowledge, the first insight into the binding mode of a peptide agonist to a GPCR and may support the development of non-peptide ligands that could be useful in the treatment of neurol. disorders, cancer and obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMGexg96PiObVg90H21EOLACvtfcHk0lgJxucuOxL4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVykt7%252FP&md5=c55a071640dec7edae7a69d715bea675</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature11558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11558%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BF.%26aulast%3DNoinaj%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DKloss%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DGvozdenovic-Jeremic%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DShiloach%26aufirst%3DJ.%26aulast%3DTate%26aufirst%3DC.%2BG.%26aulast%3DGrisshammer%26aufirst%3DR.%26atitle%3DStructure%2520of%2520the%2520agonist-bound%2520neurotensin%2520receptor%26jtitle%3DNature%26date%3D2012%26volume%3D490%26spage%3D508%26epage%3D513%26doi%3D10.1038%2Fnature11558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillenbrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlinkmann, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plückthun, A.</span></span> <span> </span><span class="NLM_article-title">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">E655</span>– <span class="NLM_lpage">E662</span>, <span class="refDoi"> DOI: 10.1073/pnas.1317903111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1073%2Fpnas.1317903111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=24453215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E655-E662&issue=6&author=P.+Egloffauthor=M.+Hillenbrandauthor=C.+Klenkauthor=A.+Batyukauthor=P.+Heineauthor=S.+Baladaauthor=K.+M.+Schlinkmannauthor=D.+J.+Scottauthor=M.+Sch%C3%BCtzauthor=A.+Pl%C3%BCckthun&title=Structure+of+signaling-competent+neurotensin+receptor+1+obtained+by+directed+evolution+in+Escherichia+coli&doi=10.1073%2Fpnas.1317903111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span></div><div class="casAuthors">Egloff, Pascal; Hillenbrand, Matthias; Klenk, Christoph; Batyuk, Alexander; Heine, Philipp; Balada, Stefanie; Schlinkmann, Karola M.; Scott, Daniel J.; Schutz, Marco; Pluckthun, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">E655-E662</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Crystallog. has advanced our understanding of G protein-coupled receptors, but low expression levels and instability in soln. have limited structural insights to very few selected members of this large protein family.  Using neurotensin receptor 1 (NTR1) as a proof of principle, we show that two directed evolution technologies that we recently developed have the potential to overcome these problems.  We purified three neurotensin-bound NTR1 variants from Escherichia coli and detd. their x-ray structures at up to 2.75 Å resoln. using vapor diffusion crystn. expts.  A crystd. construct was pharmacol. characterized and exhibited ligand-dependent signaling, internalization, and wild-type-like agonist and antagonist affinities.  Our structures are fully consistent with all biochem. defined ligand-contacting residues, and they represent an inactive NTR1 state at the cytosolic side.  They exhibit significant differences to a previously detd. NTR1 structure (Protein Data Bank ID code 4GRV) in the ligand-binding pocket and by the presence of the amphipathic helix 8.  A comparison of helix 8 stability determinants between NTR1 and other crystd. G protein-coupled receptors suggests that the occupancy of the canonical position of the amphipathic helix is reduced to various extents in many receptors, and we have elucidated the sequence determinants for a stable helix 8.  Our anal. also provides a structural rationale for the long-known effects of C-terminal palmitoylation reactions on G protein-coupled receptor signaling, receptor maturation, and desensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEqfddVgyHFLVg90H21EOLACvtfcHk0lgJxucuOxL4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D&md5=036230389cacc05a6462cf7b6a55278b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1317903111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1317903111%26sid%3Dliteratum%253Aachs%26aulast%3DEgloff%26aufirst%3DP.%26aulast%3DHillenbrand%26aufirst%3DM.%26aulast%3DKlenk%26aufirst%3DC.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DHeine%26aufirst%3DP.%26aulast%3DBalada%26aufirst%3DS.%26aulast%3DSchlinkmann%26aufirst%3DK.%2BM.%26aulast%3DScott%26aufirst%3DD.%2BJ.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DM.%26aulast%3DPl%25C3%25BCckthun%26aufirst%3DA.%26atitle%3DStructure%2520of%2520signaling-competent%2520neurotensin%2520receptor%25201%2520obtained%2520by%2520directed%2520evolution%2520in%2520Escherichia%2520coli%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D6%26spage%3DE655%26epage%3DE662%26doi%3D10.1073%2Fpnas.1317903111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griebel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsboer, F.</span></span> <span> </span><span class="NLM_article-title">Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1038/nrd3702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1038%2Fnrd3702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=22596253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFyru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=462-478&author=G.+Griebelauthor=F.+Holsboer&title=Neuropeptide+receptor+ligands+as+drugs+for+psychiatric+diseases%3A+the+end+of+the+beginning%3F&doi=10.1038%2Fnrd3702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?</span></div><div class="casAuthors">Griebel, Guy; Holsboer, Florian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">462-478</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The search for novel drugs for treating psychiatric disorders is driven by the growing medical need to improve on the effectiveness and side-effect profile of currently available therapies.  Given the wealth of preclin. data supporting the role of neuropeptides in modulating behavior, pharmaceutical companies have been attempting to target neuropeptide receptors for over two decades.  However, clin. studies with synthetic neuropeptide ligands have been unable to confirm the promise predicted by studies in animal models.  Here, we analyze preclin. and clin. results for neuropeptide receptor ligands that have been studied in clin. trials for psychiatric diseases, including agents that target the receptors for tachykinins, corticotropin-releasing factor, vasopressin and neurotensin, and suggest new ways to exploit the full potential of these candidate drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAyxMYykGx07Vg90H21EOLACvtfcHk0lgJxucuOxL4zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFyru70%253D&md5=b9aaf2b537fb73cac78d0654f0c80ed9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd3702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3702%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DHolsboer%26aufirst%3DF.%26atitle%3DNeuropeptide%2520receptor%2520ligands%2520as%2520drugs%2520for%2520psychiatric%2520diseases%253A%2520the%2520end%2520of%2520the%2520beginning%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D462%26epage%3D478%26doi%3D10.1038%2Fnrd3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hadden, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwig, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokko, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, T. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8–13) analogues containing non-natural arginine and lysine residues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.neuropharm.2005.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=16095636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ejs77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1149-1159&author=M.+K.+Haddenauthor=K.+S.+Orwigauthor=K.+P.+Kokkoauthor=J.+Mazellaauthor=T.+A.+Dix&title=Design%2C+synthesis%2C+and+evaluation+of+the+antipsychotic+potential+of+orally+bioavailable+neurotensin+%288%E2%80%9313%29+analogues+containing+non-natural+arginine+and+lysine+residues&doi=10.1016%2Fj.neuropharm.2005.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues</span></div><div class="casAuthors">Hadden, M. Kyle; Orwig, Kevin S.; Kokko, Kyle P.; Mazella, Jean; Dix, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1149-1159</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotensin (NT) and its active fragment NT(8-13) elicit behavioral responses typical of clin. used antipsychotic drugs when administered directly to the brain.  However, limited peptide stability and oral bioavailability have prevented these compds. from being developed as relevant pharmaceuticals.  Recently, our lab. designed and studied a first-generation NT(8-13) deriv., KK13, that elicited key pharmacokinetic and behavioral responses typical of clin. used antipsychotic drugs when administered to rats parenterally.  This compd. was the basis for the rational design of a series of second-generation NT(8-13) analogs (KH1-KH30) studied in this paper.  Initial screening of these analogs for CNS activity by monitoring hypothermia induction after peripheral administration defined several compds. (KH11, KH24, KH26, and KH28-KH30) that warranted further investigation.  Each compd. maintained binding affinity for NTR1, however, only KH24, KH26, and KH28 (as well as KK13) elicited significant hypothermic responses after oral administration.  Of these, KH28 demonstrated an oral activity 3-fold greater than any other analog; hence it was further characterized in a series of rat behavioral assays.  KH28 attenuated D-amphetamine induced hyperlocomotion, a hallmark of current clin. effective antipsychotic drugs, after both IP and oral administration.  In addn., tolerance to the compd. did not develop after repeated daily dosing, as measured by hypothermic induction as well as attenuation of D-amphetamine induced hyperlocomotion.  Finally, KH28 did not produce catalepsy, a deleterious side-effect elicited by classical antipsychotic drugs.  KH28 is considered to be an ideal compd. for further development as a potential novel antipsychotic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmjBoV7ura1bVg90H21EOLACvtfcHk0lhFV7KYXgx3JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ejs77I&md5=4bcc22660bda0140c9bfdfbd722c4ddf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DHadden%26aufirst%3DM.%2BK.%26aulast%3DOrwig%26aufirst%3DK.%2BS.%26aulast%3DKokko%26aufirst%3DK.%2BP.%26aulast%3DMazella%26aufirst%3DJ.%26aulast%3DDix%26aufirst%3DT.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520the%2520antipsychotic%2520potential%2520of%2520orally%2520bioavailable%2520neurotensin%2520%25288%25E2%2580%259313%2529%2520analogues%2520containing%2520non-natural%2520arginine%2520and%2520lysine%2520residues%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D1149%26epage%3D1159%26doi%3D10.1016%2Fj.neuropharm.2005.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boigegrain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanjean, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molimard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poncelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueudet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heaulme, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouard, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.1.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1073%2Fpnas.90.1.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=8380498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK3sXhs1Srurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=65-69&author=D.+Gullyauthor=M.+Cantonauthor=R.+Boigegrainauthor=F.+Jeanjeanauthor=J.+C.+Molimardauthor=M.+Ponceletauthor=C.+Gueudetauthor=M.+Heaulmeauthor=R.+Leyrisauthor=A.+Brouard&title=Biochemical+and+pharmacological+profile+of+a+potent+and+selective+nonpeptide+antagonist+of+the+neurotensin+receptor&doi=10.1073%2Fpnas.90.1.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor</span></div><div class="casAuthors">Gully, Danielle; Canton, Maryse; Boigegrain, Robert; Jeanjean, Francis; Molimard, Jean Charles; Poncelet, Martine; Gueudet, Christiane; Heaulme, Michel; Leyris, Roger; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">We describe the characteristics of SR 48692 (I), a selective, nonpeptide antagonist of the neurotensin receptor.  In vitro, this compd. competitively inhibits 125I-labeled neurotensin binding to the high-affinity binding site present in brain tissue from various species with IC50 values of 0.99 nM (guinea pig), 4.0 nM (rat mesencephalic cells), 7.6 nM (COS-7 cells transfected with the cloned high-affinity rat brain receptor), 13.7 nM (newborn mouse brain), 17.8 nM (newborn human brain), 8.7 nM (adult human brain), and 30.3 nM (HT-29 cells).  It also displaces 125I-labeled neurotensin from the low-affinity levocabastine-sensitive binding sites but at higher concns. (34.8 nM for adult mouse brain and 82.0 nM for adult rat brain).  In guinea pig striatal slices, SR 48692 blocks K+-evoked release of [3H]dopamine stimulated by neurotensin with a potency (IC50 = 0.46 nM) that correlates with its binding affinity.  In a cell line derived from a human colon carcinoma (HT-29), SR 48692 competitively antagonizes neurotensin-induced intracellular Ca2+ mobilization with a pA2 (-log K3app) values of 8.13, which is consistent with results obtained in binding studies.  Moreover, SR 48692 is devoid of any intrinsic agonist activity.  This compd. is also active in vivo, since it reverses at low dose (80 μg/kg) the turning behavior induced by intrastriatal injection of neurotensin in mice with similar potency whatever the route of administration (i.p. or orally) and with a long duration of action (6 h).  Thus, being a potent and selective neurotensin receptor antagonist, SR 48692 may be considered as a powerful tool for investigating the role of neurotensin in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9FBuoak0ov7Vg90H21EOLACvtfcHk0lhFV7KYXgx3JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhs1Srurk%253D&md5=89cfbc973e5cce0e7af8d14f943c98f6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.1.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.1.65%26sid%3Dliteratum%253Aachs%26aulast%3DGully%26aufirst%3DD.%26aulast%3DCanton%26aufirst%3DM.%26aulast%3DBoigegrain%26aufirst%3DR.%26aulast%3DJeanjean%26aufirst%3DF.%26aulast%3DMolimard%26aufirst%3DJ.%2BC.%26aulast%3DPoncelet%26aufirst%3DM.%26aulast%3DGueudet%26aufirst%3DC.%26aulast%3DHeaulme%26aufirst%3DM.%26aulast%3DLeyris%26aufirst%3DR.%26aulast%3DBrouard%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520pharmacological%2520profile%2520of%2520a%2520potent%2520and%2520selective%2520nonpeptide%2520antagonist%2520of%2520the%2520neurotensin%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D65%26epage%3D69%26doi%3D10.1073%2Fpnas.90.1.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeeuw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boigegrain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oury-Donat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poncelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suaud-Chagny, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecceu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbe- Jullie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubrie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Fur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffrand, J. P.</span></span> <span> </span><span class="NLM_article-title">Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">812</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=9023294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK2sXivVWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1997&pages=802-812&author=D.+Gullyauthor=B.+Labeeuwauthor=R.+Boigegrainauthor=F.+Oury-Donatauthor=A.+Bachyauthor=M.+Ponceletauthor=R.+Steinbergauthor=M.+F.+Suaud-Chagnyauthor=V.+Santucciauthor=N.+Vitaauthor=F.+Pecceuauthor=C.+Labbe-+Jullieauthor=P.+Kitabgiauthor=P.+Soubrieauthor=G.+Le+Furauthor=J.+P.+Maffrand&title=Biochemical+and+pharmacological+activities+of+SR+142948A%2C+a+new+potent+neurotensin+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist</span></div><div class="casAuthors">Gully, Danielle; Labeeuw, Bernard; Biogegrain, Robert; Oury-Donat, Florence; Bachy, Andre; Poncelet, Martine; Steinberg, Regis; Suaud-Chagny, Marie Francoise; Santucci, Vincent; Vita, Natalio; Pecceu, Florence; Labbe-Jullie, Catherine; Kitabgi, Patrick; Soubrie, Philippe; Le Fur, Gerard; Maffrand, Jean Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">802-812</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">SR 142948A, 2-{[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methylcarbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]amino}adamantane-2-carboxylic acid, hydrochloride, a new and extremely potent neurotensin (NT) receptor antagonist, has been characterized in comparison with SR 48692.  This selective compd. possesses nanomolar affinities for NT receptors, recognizes the two binding sites described for the NT receptor and fully displaces [3H]Sr 48692 specific binding.  SR 142948A antagonizes the classical in vitro NT effects, i.e.l, inositol monophosphate formation in HT 29 cells (IC50 = 3.9 nM) or intracellular calcium mobilization in Chinese hamster ovary cells transfected with the human receptor.  It dose-dependently (0.04-640×10-3 mg./kg p.o.) inhibits the turning behavior induced by unilateral intrastriatal injection of NT in mice, with the biphasic profile previously seen for SR 48692.  At 0.1 mg/kg (i.p.), it completely antagonizes NT-evoked acetylcholine release in the rat striatum.  In contrast to SR 48692, SR 142948A (p.o.) blocks both hypothermia and analgesia induced by i.c.v. injection of NT (mice and/or rats) but is unable to modify the dopamine release evoked by NT injection into the central tegmental area.  In summary, SR 142948A retains the properties of the lead compd. SR 48692 (no intrinsic agonist activity, oral bioavailability, long duration of action and good brain access), reveals a wider spectrum of activity than SR 48692 (probably due to the inhibition of NT receptor subtypes) and represents an addnl. tool for further exploration of the therapeutic potential of this class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpycUQVvgjnErVg90H21EOLACvtfcHk0lhFV7KYXgx3JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVWkurk%253D&md5=30218d6e53cc7bd8ab180657116ab7df</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGully%26aufirst%3DD.%26aulast%3DLabeeuw%26aufirst%3DB.%26aulast%3DBoigegrain%26aufirst%3DR.%26aulast%3DOury-Donat%26aufirst%3DF.%26aulast%3DBachy%26aufirst%3DA.%26aulast%3DPoncelet%26aufirst%3DM.%26aulast%3DSteinberg%26aufirst%3DR.%26aulast%3DSuaud-Chagny%26aufirst%3DM.%2BF.%26aulast%3DSantucci%26aufirst%3DV.%26aulast%3DVita%26aufirst%3DN.%26aulast%3DPecceu%26aufirst%3DF.%26aulast%3DLabbe-%2BJullie%26aufirst%3DC.%26aulast%3DKitabgi%26aufirst%3DP.%26aulast%3DSoubrie%26aufirst%3DP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26atitle%3DBiochemical%2520and%2520pharmacological%2520activities%2520of%2520SR%2520142948A%252C%2520a%2520new%2520potent%2520neurotensin%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D280%26spage%3D802%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmour, B.</span></span> <span> </span><span class="NLM_article-title">The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1438</span>– <span class="NLM_lpage">1441</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.bmcl.2009.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=19195889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1438-1441&author=J.+B.+Thomasauthor=H.+Navarroauthor=K.+R.+Warnerauthor=B.+Gilmour&title=The+identification+of+nonpeptide+neurotensin+receptor+partial+agonists+from+the+potent+antagonist+SR48692+using+a+calcium+mobilization+assay&doi=10.1016%2Fj.bmcl.2009.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay</span></div><div class="casAuthors">Thomas, James B.; Navarro, Hernan; Warner, Keith R.; Gilmour, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1438-1441</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In a search for nonpeptide agonists for the neurotensin receptor (NTR1), we replaced the adamantyl amino acid moiety found in the antagonist SR48692 (1a) with leucine and related α-alkylamino acids found in peptide agonists.  When tested in a calcium mobilization assay, we found that both - and -leucine confer partial agonist activity to the pyrazole scaffold with the -enantiomer (3a) providing a significantly greater response.  A brief SAR survey demonstrated that the obsd. agonist activity was resilient to changes made to the dimethoxyaryl ring in 3a.  The resulting compds. were less potent relative to 3a but showed greater agonist responses.  The partial agonist activity was extinguished when the chloroquinoline ring was replaced with naphthalene.  Thus, while L-leucine appears to possess a powerful agonist directing affect for the NTR1 receptor, its presence alone in the mol. architecture is not sufficient to insure agonist behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB3thhb1eSV7Vg90H21EOLACvtfcHk0lhxUXM29XXQ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wmsbs%253D&md5=c74adc0e9bd526a5f36c206306fc5f4d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DNavarro%26aufirst%3DH.%26aulast%3DWarner%26aufirst%3DK.%2BR.%26aulast%3DGilmour%26aufirst%3DB.%26atitle%3DThe%2520identification%2520of%2520nonpeptide%2520neurotensin%2520receptor%2520partial%2520agonists%2520from%2520the%2520potent%2520antagonist%2520SR48692%2520using%2520a%2520calcium%2520mobilization%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1438%26epage%3D1441%26doi%3D10.1016%2Fj.bmcl.2009.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peddibhotla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangravita- Novo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosalia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicchiarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barak, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, G. P.</span></span> <span> </span><span class="NLM_article-title">Imidazole-derived agonists for the neurotensin 1 receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.bmcl.2013.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=24332089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOrurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=262-267&author=P.+M.+Hershbergerauthor=M.+P.+Hedrickauthor=S.+Peddibhotlaauthor=A.+Mangravita-+Novoauthor=P.+Gosaliaauthor=Y.+Liauthor=W.+Grayauthor=M.+Vicchiarelliauthor=L.+H.+Smithauthor=T.+D.+Chungauthor=J.+B.+Thomasauthor=M.+G.+Caronauthor=A.+B.+Pinkertonauthor=L.+S.+Barakauthor=G.+P.+Roth&title=Imidazole-derived+agonists+for+the+neurotensin+1+receptor&doi=10.1016%2Fj.bmcl.2013.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazole-derived agonists for the neurotensin 1 receptor</span></div><div class="casAuthors">Hershberger, Paul M.; Hedrick, Michael P.; Peddibhotla, Satyamaheshwar; Mangravita-Novo, Arianna; Gosalia, Palak; Li, Yujie; Gray, Wilson; Vicchiarelli, Michael; Smith, Layton H.; Chung, Thomas D. Y.; Thomas, James B.; Caron, Marc G.; Pinkerton, Anthony B.; Barak, Lawrence S.; Roth, Gregory P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">262-267</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A scaffold-hop program seeking full agonists of the neurotensin-1 (NTR1) receptor identified the probe mol. ML301 (1) and assocd. analogs, including its naphthyl analog (14) which exhibited similar properties.  Compd. 1 showed full agonist behavior (79-93%) with an EC50 of 2.0-4.1 μM against NTR1.  Compd. 1 also showed good activity in a Ca mobilization FLIPR assay (93% efficacy at 298 nM), consistent with it functioning via the Gq coupled pathway, and good selectivity relative to NTR2 and GPR35.  In further profiling, 1 showed low potential for promiscuity and good overall pharmacol. data.  This report describes the discovery, synthesis, and SAR of 1 and assocd. analogs.  Initial in vitro pharmacol. characterization is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwenmL-YqLj7Vg90H21EOLACvtfcHk0lhxUXM29XXQ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOrurjI&md5=eea781b7c7e912f85cddec433a2fe557</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DHershberger%26aufirst%3DP.%2BM.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DPeddibhotla%26aufirst%3DS.%26aulast%3DMangravita-%2BNovo%26aufirst%3DA.%26aulast%3DGosalia%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DW.%26aulast%3DVicchiarelli%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DL.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26atitle%3DImidazole-derived%2520agonists%2520for%2520the%2520neurotensin%25201%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D262%26epage%3D267%26doi%3D10.1016%2Fj.bmcl.2013.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andree, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollings, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pausch, M. H.</span></span> <span> </span><span class="NLM_article-title">The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5789</span>– <span class="NLM_lpage">5791</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.09.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.bmcl.2008.09.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=18849166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12rs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5789-5791&author=Y.+Fanauthor=M.+H.+Laiauthor=K.+Sullivanauthor=M.+Popiolekauthor=T.+H.+Andreeauthor=P.+Dollingsauthor=M.+H.+Pausch&title=The+identification+of+neurotensin+NTS1+receptor+partial+agonists+through+a+ligand-based+virtual+screening+approach&doi=10.1016%2Fj.bmcl.2008.09.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach</span></div><div class="casAuthors">Fan, Yi; Lai, Margaret H.; Sullivan, Kelly; Popiolek, Michael; Andree, Terrance H.; Dollings, Paul; Pausch, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5789-5791</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We identified small mol. NTS1R agonist compds. through virtual screening of the corporate database using a ROCS approach that searches multi-conformer representations efficiently.  As a starting point for the ROCS search, we used the known NTS1R selective antagonist, SR-48527, based on the hypothesis that NT agonists and antagonists might share similar binding regions.  Conformations were expanded and selected as database search queries based on a cluster anal.  The search provided us with virtual hits that were tested in intracellular calcium mobilization assays of NTS1R agonist and antagonist activities measured in FLIPR format as well as in [3H]NT competition binding studies.  The results indicated that two initial hits produced partial agonist activity with potency in the moderate micromolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-XBoLKqs9Y7Vg90H21EOLACvtfcHk0lhxUXM29XXQ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12rs77L&md5=1b24b770894b7ad4c19a0dab551f2ae1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.09.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.09.075%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DM.%2BH.%26aulast%3DSullivan%26aufirst%3DK.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DDollings%26aufirst%3DP.%26aulast%3DPausch%26aufirst%3DM.%2BH.%26atitle%3DThe%2520identification%2520of%2520neurotensin%2520NTS1%2520receptor%2520partial%2520agonists%2520through%2520a%2520ligand-based%2520virtual%2520screening%2520approach%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5789%26epage%3D5791%26doi%3D10.1016%2Fj.bmcl.2008.09.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Fruscia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizifard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1) Bioorg</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3974</span>– <span class="NLM_lpage">3978</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.bmcl.2014.06.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=24997685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWgt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3974-3978&author=P.+Di%0AFrusciaauthor=Y.+Heauthor=M.+Koenigauthor=S.+Tabrizifardauthor=A.+Nietoauthor=P.+H.+McDonaldauthor=T.+M.+Kamenecka&title=The+discovery+of+indole+full+agonists+of+the+neurotensin+receptor+1+%28NTSR1%29+Bioorg&doi=10.1016%2Fj.bmcl.2014.06.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1)</span></div><div class="casAuthors">Di Fruscia, Paolo; He, Yuanjun; Koenig, Marcel; Tabrizifard, Sahba; Nieto, Ainhoa; McDonald, Patricia H.; Kamenecka, Theodore M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3974-3978</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotensin (NT) is an endogenous tridecapeptide found in the central nervous system (CNS) and in peripheral tissues.  Neurotensin exerts a wide range of physiol. effects and it has been found to play a crit. role in a no. of human diseases, such as schizophrenia, Parkinson's disease and drug addiction.  The discovery of small-mol. non-peptide neurotensin receptor (NTSR) modulators would represent an important breakthrough as such compds. could be used as pharmacol. tools, to further decipher the cellular functions of neurotensin, and potentially as therapeutic agents to treat human disease.  Herein, we report the identification of non-peptide low-micromolar neurotensin receptor 1 (NTSR1) full agonists, discovered through structural optimization of the known NTSR1 partial agonist 1.  In vitro cellular screenings, based on an intracellular Ca2+ mobilization assay, revealed our best hit mol. 8 (SR-12062) to have an EC50 of 2 μM at NTSR1 with full agonist behavior (Emax = 100%), showing a higher efficacy and ∼90-fold potency improvement compared to parent compd. 1 (EC50 = 178 μM; Emax = 17%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodSx4caog6BrVg90H21EOLACvtfcHk0lgEYVnlxDOPKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWgt77O&md5=e1707922eddb096a555bf2aed2d9ff1c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.033%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFruscia%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DKoenig%26aufirst%3DM.%26aulast%3DTabrizifard%26aufirst%3DS.%26aulast%3DNieto%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DP.%2BH.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26atitle%3DThe%2520discovery%2520of%2520indole%2520full%2520agonists%2520of%2520the%2520neurotensin%2520receptor%25201%2520%2528NTSR1%2529%2520Bioorg%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3974%26epage%3D3978%26doi%3D10.1016%2Fj.bmcl.2014.06.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peddibhotla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milewski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosalia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugarman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suyama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heynen-Genel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salaniwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stonich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangravita-Novo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicchiarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barak, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of ML314, a Brain Penetrant Non-Peptidic beta-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1021/ml400176n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400176n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCmu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=846-851&author=S.+Peddibhotlaauthor=M.+P.+Hedrickauthor=P.+Hershbergerauthor=P.+R.+Maloneyauthor=Y.+Liauthor=M.+Milewskiauthor=P.+Gosaliaauthor=W.+Grayauthor=A.+Mehtaauthor=E.+Sugarmanauthor=B.+Hoodauthor=E.+Suyamaauthor=K.+Nguyenauthor=S.+Heynen-Genelauthor=S.+Vasileauthor=S.+Salaniwalauthor=D.+Stonichauthor=Y.+Suauthor=A.+Mangravita-Novoauthor=M.+Vicchiarelliauthor=G.+P.+Rothauthor=L.+H.+Smithauthor=T.+D.+Chungauthor=G.+R.+Hansonauthor=J.+B.+Thomasauthor=M.+G.+Caronauthor=L.+S.+Barakauthor=A.+B.+Pinkerton&title=Discovery+of+ML314%2C+a+Brain+Penetrant+Non-Peptidic+beta-Arrestin+Biased+Agonist+of+the+Neurotensin+NTR1+Receptor&doi=10.1021%2Fml400176n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ML314, a Brain Penetrant Nonpeptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor</span></div><div class="casAuthors">Peddibhotla, Satyamaheshwar; Hedrick, Michael P.; Hershberger, Paul; Maloney, Patrick R.; Li, Yujie; Milewski, Monika; Gosalia, Palak; Gray, Wilson; Mehta, Alka; Sugarman, Eliot; Hood, Becky; Suyama, Eigo; Nguyen, Kevin; Heynen-Genel, Susanne; Vasile, Stefan; Salaniwal, Sumeet; Stonich, Derek; Su, Ying; Mangravita-Novo, Arianna; Vicchiarelli, Michael; Roth, Gregory P.; Smith, Layton H.; Chung, Thomas D. Y.; Hanson, Glen R.; Thomas, James B.; Caron, Marc G.; Barak, Lawrence S.; Pinkerton, Anthony B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">846-851</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotensin 1 receptor (NTR1) is an important therapeutic target for a range of disease states including addiction.  A high-throughput screening campaign, followed by medicinal chem. optimization, led to the discovery of a nonpeptidic β-arrestin biased agonist for NTR1.  The lead compd., 2-cyclopropyl-6,7-dimethoxy-4-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline, 32 (I, ML314), exhibits full agonist behavior against NTR1 (EC50 = 2.0 μM) in the primary assay and selectivity against NTR2.  The effect of 32 is blocked by the NTR1 antagonist SR142948A in a dose-dependent manner.  Unlike peptide-based NTR1 agonists, compd. 32 has no significant response in a Ca2+ mobilization assay and is thus a biased agonist that activates the β-arrestin pathway rather than the traditional Gq coupled pathway.  This bias has distinct biochem. and functional consequences that may lead to physiol. advantages.  Compd. 32 displays good brain penetration in rodents, and studies examg. its in vivo properties are underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxTEeUPENaGbVg90H21EOLACvtfcHk0lgEYVnlxDOPKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCmu7rL&md5=79025bb9edba860732cdeff77a0a506e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml400176n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400176n%26sid%3Dliteratum%253Aachs%26aulast%3DPeddibhotla%26aufirst%3DS.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DHershberger%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMilewski%26aufirst%3DM.%26aulast%3DGosalia%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DW.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DSugarman%26aufirst%3DE.%26aulast%3DHood%26aufirst%3DB.%26aulast%3DSuyama%26aufirst%3DE.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DHeynen-Genel%26aufirst%3DS.%26aulast%3DVasile%26aufirst%3DS.%26aulast%3DSalaniwal%26aufirst%3DS.%26aulast%3DStonich%26aufirst%3DD.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DMangravita-Novo%26aufirst%3DA.%26aulast%3DVicchiarelli%26aufirst%3DM.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DSmith%26aufirst%3DL.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520of%2520ML314%252C%2520a%2520Brain%2520Penetrant%2520Non-Peptidic%2520beta-Arrestin%2520Biased%2520Agonist%2520of%2520the%2520Neurotensin%2520NTR1%2520Receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D846%26epage%3D851%26doi%3D10.1021%2Fml400176n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barak, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evron, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urs, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peddibhotla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1880</span>– <span class="NLM_lpage">1890</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00291</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmsl2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1880-1890&author=L.+S.+Barakauthor=Y.+Baiauthor=S.+Petersonauthor=T.+Evronauthor=N.+M.+Ursauthor=S.+Peddibhotlaauthor=M.+P.+Hedrickauthor=P.+Hershbergerauthor=P.+R.+Maloneyauthor=T.+D.+Y.+Chungauthor=R.+M.+Rodriguizauthor=W.+C.+Wetselauthor=J.+B.+Thomasauthor=G.+R.+Hansonauthor=A.+B.+Pinkertonauthor=M.+G.+Caron&title=ML314%3A+A+Biased+Neurotensin+Receptor+Ligand+for+Methamphetamine+Abuse&doi=10.1021%2Facschembio.6b00291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse</span></div><div class="casAuthors">Barak, Larry S.; Bai, Yushi; Peterson, Sean; Evron, Tama; Urs, Nikhil M.; Peddibhotla, Satyamaheshwar; Hedrick, Michael P.; Hershberger, Paul; Maloney, Patrick R.; Chung, Thomas D. Y.; Rodriguiz, Ramona M.; Wetsel, William C.; Thomas, James B.; Hanson, Glen R.; Pinkerton, Anthony B.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1880-1890</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pharmacol. treatment for methamphetamine addiction will provide important societal benefits.  Neurotensin receptor NTR1 and dopamine receptor distributions coincide in brain areas regulating methamphetamine-assocd. reward, and neurotensin peptides produce behaviors opposing psychostimulants.  Therefore, undesirable methamphetamine-assocd. activities should be treatable with druggable NTR1 agonists, but no such FDA-approved therapeutics exist.  We address this limitation with proof-of-concept data for ML314, a small-mol., brain penetrant, β-arrestin biased, NTR1 agonist.  ML314 attenuates amphetamine-like hyperlocomotion in dopamine transporter knockout mice, and in C57BL/6J mice it attenuates methamphetamine-induced hyperlocomotion, potentiates the psychostimulant inhibitory effects of a ghrelin antagonist, and reduces methamphetamine-assocd. conditioned place preference.  In rats, ML314 blocks methamphetamine self-administration.  ML314 acts as an allosteric enhancer of endogenous neurotensin, unmasking stoichiometric nos. of hidden NTR1 binding sites in transfected-cell membranes or mouse striatal membranes, while addnl. supporting NTR1 endocytosis in cells in the absence of NT peptide.  These results indicate ML314 is a viable, preclin. lead for methamphetamine abuse treatment and support an allosteric model of G protein-coupled receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRELv0YzCr9bVg90H21EOLACvtfcHk0lg5trlRC61dYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmsl2rtbY%253D&md5=48872ea73457f91e63a8631117848ecd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00291%26sid%3Dliteratum%253Aachs%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DEvron%26aufirst%3DT.%26aulast%3DUrs%26aufirst%3DN.%2BM.%26aulast%3DPeddibhotla%26aufirst%3DS.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DHershberger%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DChung%26aufirst%3DT.%2BD.%2BY.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DML314%253A%2520A%2520Biased%2520Neurotensin%2520Receptor%2520Ligand%2520for%2520Methamphetamine%2520Abuse%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D1880%26epage%3D1890%26doi%3D10.1021%2Facschembio.6b00291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Hershberger, P. M.</span>; <span class="NLM_string-name">Peddibhotla, S.</span>; <span class="NLM_string-name">Maloney, P. R.</span>; <span class="NLM_string-name">Hedrick, M. P.</span></span> <span> </span><span class="NLM_article-title">Preparation of substituted quinazolines as small molecule agonists of neurotensin receptor 1</span>. PCT WO <span class="NLM_patent">2015200534</span>, Dec 30, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+B.+Pinkerton&author=P.+M.+Hershberger&author=S.+Peddibhotla&author=P.+R.+Maloney&author=M.+P.+Hedrick&title=Preparation+of+substituted+quinazolines+as+small+molecule+agonists+of+neurotensin+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26atitle%3DPreparation%2520of%2520substituted%2520quinazolines%2520as%2520small%2520molecule%2520agonists%2520of%2520neurotensin%2520receptor%25201%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P.</span>; <span class="NLM_string-name">Hedrick, M.</span>; <span class="NLM_string-name">Peddibhotla, S.</span>; <span class="NLM_string-name">Maloney, P.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Milewski, M.</span>; <span class="NLM_string-name">Gosalia, P.</span>; <span class="NLM_string-name">Gray, W.</span>; <span class="NLM_string-name">Mehta, A.</span>; <span class="NLM_string-name">Sugarman, E.</span>; <span class="NLM_string-name">Hood, B.</span>; <span class="NLM_string-name">Suyama, E.</span>; <span class="NLM_string-name">Nguyen, K.</span>; <span class="NLM_string-name">Heynen-Genel, S.</span>; <span class="NLM_string-name">Vasile, S.</span>; <span class="NLM_string-name">Salaniwal, S.</span>; <span class="NLM_string-name">Stonich, D.</span>; <span class="NLM_string-name">Su, Y.</span>; <span class="NLM_string-name">Mangravita-Novo, A.</span>; <span class="NLM_string-name">Vicchiarelli, M.</span>; <span class="NLM_string-name">Smith, L. H.</span>; <span class="NLM_string-name">Roth, G.</span>; <span class="NLM_string-name">Diwan, J.</span>; <span class="NLM_string-name">Chung, T. D. Y.</span>; <span class="NLM_string-name">Caron, M. G.</span>; <span class="NLM_string-name">Thomas, J. B.</span>; <span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Barak, L. R.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Agonists for the Neurotensin 1 Receptor (NTR1 Agonists)</span>.  <i>Probe Reports from the NIH Molecular Libraries Program</i>; <span class="NLM_publisher-name">U.S. National Center for Biotechnology Information</span>, <span class="NLM_year">2010</span>–<span class="NLM_year">2012</span>; <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/493036" class="extLink">https://pubchem.ncbi.nlm.nih.gov/bioassay/493036</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=P.+Hershberger&author=M.+Hedrick&author=S.+Peddibhotla&author=P.+Maloney&author=Y.+Li&author=M.+Milewski&author=P.+Gosalia&author=W.+Gray&author=A.+Mehta&author=E.+Sugarman&author=B.+Hood&author=E.+Suyama&author=K.+Nguyen&author=S.+Heynen-Genel&author=S.+Vasile&author=S.+Salaniwal&author=D.+Stonich&author=Y.+Su&author=A.+Mangravita-Novo&author=M.+Vicchiarelli&author=L.+H.+Smith&author=G.+Roth&author=J.+Diwan&author=T.+D.+Y.+Chung&author=M.+G.+Caron&author=J.+B.+Thomas&author=A.+B.+Pinkerton&author=L.+R.+Barak&title=Small+Molecule+Agonists+for+the+Neurotensin+1+Receptor+%28NTR1+Agonists%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DHershberger%26aufirst%3DP.%26atitle%3DSmall%2520Molecule%2520Agonists%2520for%2520the%2520Neurotensin%25201%2520Receptor%2520%2528NTR1%2520Agonists%2529%26jtitle%3DProbe%2520Reports%2520from%2520the%2520NIH%2520Molecular%2520Libraries%2520Program%26pub%3DU.S.%2520National%2520Center%2520for%2520Biotechnology%2520Information%26date%3D2010%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slosky, L. M.</span>; <span class="NLM_string-name">Bai, Y.</span>; <span class="NLM_string-name">Toth, K.</span>; <span class="NLM_string-name">Rochelle, L. K.</span>; <span class="NLM_string-name">Ray, C.</span>; <span class="NLM_string-name">Badea, A.</span>; <span class="NLM_string-name">Pogorelov, V.</span>; <span class="NLM_string-name">Chandrasekhar, R.</span>; <span class="NLM_string-name">Abraham, D. M.</span>; <span class="NLM_string-name">Atluri, N.</span>; <span class="NLM_string-name">Peddibhotla, S.</span>; <span class="NLM_string-name">Hedrick, M. P.</span>; <span class="NLM_string-name">Hershberger, P.</span>; <span class="NLM_string-name">Maloney, P.</span>; <span class="NLM_string-name">Yuan, H.</span>; <span class="NLM_string-name">Li, Z.</span>; <span class="NLM_string-name">Wetsel, W.</span>; <span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Barak, L.</span>; <span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Allosteric Neurotensin Receptor 1 Modulator Confers β-arrestin Bias and Selectively Attenuates Addiction-Associated Behaviors</span>. Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Slosky%2C+L.+M.%3B+Bai%2C+Y.%3B+Toth%2C+K.%3B+Rochelle%2C+L.+K.%3B+Ray%2C+C.%3B+Badea%2C+A.%3B+Pogorelov%2C+V.%3B+Chandrasekhar%2C+R.%3B+Abraham%2C+D.+M.%3B+Atluri%2C+N.%3B+Peddibhotla%2C+S.%3B+Hedrick%2C+M.+P.%3B+Hershberger%2C+P.%3B+Maloney%2C+P.%3B+Yuan%2C+H.%3B+Li%2C+Z.%3B+Wetsel%2C+W.%3B+Pinkerton%2C+A.+B.%3B+Barak%2C+L.%3B+Caron%2C+M.+G.+Allosteric+Neurotensin+Receptor+1+Modulator+Confers+%CE%B2-arrestin+Bias+and+Selectively+Attenuates+Addiction-Associated+Behaviors.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DSlosky%26aufirst%3DL.%2BM.%26atitle%3DAllosteric%2520Neurotensin%2520Receptor%25201%2520Modulator%2520Confers%2520%25CE%25B2-arrestin%2520Bias%2520and%2520Selectively%2520Attenuates%2520Addiction-Associated%2520Behaviors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span> <i>NT1
Human Neurotensin GPCR Binding (Agonist Radioligand) Assay, Panlabs</i>; <span class="NLM_publisher-name">Eurofins</span>, <span class="NLM_year">2019</span>; <a href="https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/NT1-Human-Neurotensin-GPCR-Binding-Agonist-Radioligand-Assay-Panlabs/258010" class="extLink">https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/NT1-Human-Neurotensin-GPCR-Binding-Agonist-Radioligand-Assay-Panlabs/258010</a> (accessed August 1, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+NT1%0AHuman+Neurotensin+GPCR+Binding+%28Agonist+Radioligand%29+Assay%2C+Panlabs%3B+Eurofins%2C+2019%3B+https%3A%2F%2Fwww.eurofinsdiscoveryservices.com%2Fcatalogmanagement%2Fviewitem%2FNT1-Human-Neurotensin-GPCR-Binding-Agonist-Radioligand-Assay-Panlabs%2F258010+%28accessed+August+1%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DNT1%250AHuman%2520Neurotensin%2520GPCR%2520Binding%2520%2528Agonist%2520Radioligand%2529%2520Assay%252C%2520Panlabs%26pub%3DEurofins%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Efimova, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budygin, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotnikova, T. D.</span></span> <span> </span><span class="NLM_article-title">Dopamine transporter mutant animals: a translational perspective</span>. <i>J. Neurogenet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.3109/01677063.2016.1144751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.3109%2F01677063.2016.1144751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=27276191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpslyis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=5-15&issue=1&author=E.+V.+Efimovaauthor=R.+R.+Gainetdinovauthor=E.+A.+Budyginauthor=T.+D.+Sotnikova&title=Dopamine+transporter+mutant+animals%3A+a+translational+perspective&doi=10.3109%2F01677063.2016.1144751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine transporter mutant animals: a translational perspective</span></div><div class="casAuthors">Efimova, Evgeniya V.; Gainetdinov, Raul R.; Budygin, Evgeny A.; Sotnikova, Tatyana D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-15</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The dopamine transporter (DAT) plays an important homeostatic role in the control of both the extracellular and intraneuronal concns. of dopamine, thereby providing effective control over activity of dopaminergic transmission.  Since brain dopamine is known to be involved in numerous neuropsychiatric disorders, investigations using mice with genetically altered DAT function and thus intensity of dopamine-mediated signaling have provided numerous insights into the pathol. of these disorders and novel pathol. mechanisms that could be targeted to provide new therapeutic approaches for these disorders.  In this brief overview, we discuss recent investigations involving animals with genetically altered DAT function, particularly focusing on translational studies providing new insights into pathol. and pharmacol. of dopamine-related disorders.  Perspective applications of these and newly developed models of DAT dysfunction are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUioooqPwsCLVg90H21EOLACvtfcHk0ljcyBZKIptHuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpslyis7s%253D&md5=44131a75927bf32f40d580fff0b825e0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3109%2F01677063.2016.1144751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2016.1144751%26sid%3Dliteratum%253Aachs%26aulast%3DEfimova%26aufirst%3DE.%2BV.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DBudygin%26aufirst%3DE.%2BA.%26aulast%3DSotnikova%26aufirst%3DT.%2BD.%26atitle%3DDopamine%2520transporter%2520mutant%2520animals%253A%2520a%2520translational%2520perspective%26jtitle%3DJ.%2520Neurogenet.%26date%3D2016%26volume%3D30%26issue%3D1%26spage%3D5%26epage%3D15%26doi%3D10.3109%2F01677063.2016.1144751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giros, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wightman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>379</i></span> (<span class="NLM_issue">6566</span>),  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1038/379606a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1038%2F379606a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=8628395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK28XhtFKrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=606-612&issue=6566&author=B.+Girosauthor=M.+Jaberauthor=S.+R.+Jonesauthor=R.+M.+Wightmanauthor=M.+G.+Caron&title=Hyperlocomotion+and+indifference+to+cocaine+and+amphetamine+in+mice+lacking+the+dopamine+transporter&doi=10.1038%2F379606a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter</span></div><div class="casAuthors">Giros, Bruno; Jaber, Mohamed; Jones, Sara R.; Wightman, R. Mark; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6566</span>),
    <span class="NLM_cas:pages">606-12</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Disruption of the mouse dopamine transporter gene results in spontaneous hyperlocomotion despite major adaptive changes, such as decreases in neurotransmitter and receptor levels.  In homozygote mice, dopamine persists at least 100 times longer in the extracellular space, explaining the biochem. basis of the hyperdopaminergic phenotype and demonstrating the crit. role of the transporter in regulating neurotransmission.  The dopamine transporter is an obligatory target of cocaine and amphetamine, as these psychostimulants have no effect on locomotor activity or dopamine release and uptake in mice lacking the transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_SzRLVUlNDbVg90H21EOLACvtfcHk0ljcyBZKIptHuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFKrurg%253D&md5=b502613d49de0d2a3f80967440ece1a4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F379606a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379606a0%26sid%3Dliteratum%253Aachs%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DJaber%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DS.%2BR.%26aulast%3DWightman%26aufirst%3DR.%2BM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DHyperlocomotion%2520and%2520indifference%2520to%2520cocaine%2520and%2520amphetamine%2520in%2520mice%2520lacking%2520the%2520dopamine%2520transporter%26jtitle%3DNature%26date%3D1996%26volume%3D379%26issue%3D6566%26spage%3D606%26epage%3D612%26doi%3D10.1038%2F379606a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krumm, B. E.</span>; <span class="NLM_string-name">DiBerto, J. F.</span>; <span class="NLM_string-name">Olsen, R. H. J.</span>; <span class="NLM_string-name">Kang, H. J.</span>; <span class="NLM_string-name">Che, T.</span>; <span class="NLM_string-name">Slocum, S. T.</span>; <span class="NLM_string-name">Strachan, R. T.</span>; <span class="NLM_string-name">Slosky, L. M.</span>; <span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Barak, L. S.</span>; <span class="NLM_string-name">Caron, M. G.</span>; <span class="NLM_string-name">Kenakin, T.</span>; <span class="NLM_string-name">Roth, B.
L.</span></span> <span> </span><span class="NLM_article-title">Neurotensin receptor allosterism revealed in complex with a biased allosteric modulator</span>. Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Krumm%2C+B.+E.%3B+DiBerto%2C+J.+F.%3B+Olsen%2C+R.+H.+J.%3B+Kang%2C+H.+J.%3B+Che%2C+T.%3B+Slocum%2C+S.+T.%3B+Strachan%2C+R.+T.%3B+Slosky%2C+L.+M.%3B+Pinkerton%2C+A.+B.%3B+Barak%2C+L.+S.%3B+Caron%2C+M.+G.%3B+Kenakin%2C+T.%3B+Roth%2C+B.%0AL.+Neurotensin+receptor+allosterism+revealed+in+complex+with+a+biased+allosteric+modulator.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DKrumm%26aufirst%3DB.%2BE.%26atitle%3DNeurotensin%2520receptor%2520allosterism%2520revealed%2520in%2520complex%2520with%2520a%2520biased%2520allosteric%2520modulator" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 7 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities for Tapping into Three-Dimensional Chemical Space through a Quaternary Carbon. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13291-13315. <a href="https://doi.org/10.1021/acs.jmedchem.0c00829" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00829%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Bfor%252BTapping%252Binto%252BThree-Dimensional%252BChemical%252BSpace%252Bthrough%252Ba%252BQuaternary%252BCarbon%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15052020%26date%3D31082020%26date%3D17082020%26volume%3D63%26issue%3D22%26spage%3D13291%26epage%3D13315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malliga R.  Iyer</span>, <span class="hlFld-ContribAuthor ">George  Kunos</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic approaches targeting the neurotensin receptors. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (5)
                                     , 361-386. <a href="https://doi.org/10.1080/13543776.2021.1866539" title="DOI URL">https://doi.org/10.1080/13543776.2021.1866539</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1866539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1866539%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTherapeutic%252Bapproaches%252Btargeting%252Bthe%252Bneurotensin%252Breceptors%26aulast%3DIyer%26aufirst%3DMalliga%2BR.%26date%3D2021%26date%3D2021%26volume%3D31%26issue%3D5%26spage%3D361%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jariel  Ramirez-Virella</span>, <span class="hlFld-ContribAuthor ">Gina M  Leinninger</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Central Neurotensin in Regulating Feeding and Body Weight. </span><span class="cited-content_cbyCitation_journal-name">Endocrinology</span><span> <strong>2021,</strong> <em>162 </em>
                                    (5)
                                     <a href="https://doi.org/10.1210/endocr/bqab038" title="DOI URL">https://doi.org/10.1210/endocr/bqab038</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1210/endocr/bqab038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1210%2Fendocr%2Fbqab038%26sid%3Dliteratum%253Aachs%26jtitle%3DEndocrinology%26atitle%3DThe%252BRole%252Bof%252BCentral%252BNeurotensin%252Bin%252BRegulating%252BFeeding%252Band%252BBody%252BWeight%26aulast%3DRamirez-Virella%26aufirst%3DJariel%26date%3D2021%26date%3D2021%26volume%3D162%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren M.  Slosky</span>, <span class="hlFld-ContribAuthor ">Marc G.  Caron</span>, <span class="hlFld-ContribAuthor ">Lawrence S.  Barak</span>. </span><span class="cited-content_cbyCitation_article-title">Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (4)
                                     , 283-299. <a href="https://doi.org/10.1016/j.tips.2020.12.005" title="DOI URL">https://doi.org/10.1016/j.tips.2020.12.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2020.12.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2020.12.005%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DBiased%252BAllosteric%252BModulators%25253A%252BNew%252BFrontiers%252Bin%252BGPCR%252BDrug%252BDiscovery%26aulast%3DSlosky%26aufirst%3DLauren%2BM.%26date%3D2021%26volume%3D42%26issue%3D4%26spage%3D283%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yurong  Yang</span>, <span class="hlFld-ContribAuthor ">Kaixin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jian  Yang</span>, <span class="hlFld-ContribAuthor ">Guoxun  Zhu</span>, <span class="hlFld-ContribAuthor ">Weijie  Chen</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhi  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei  Yi</span>. </span><span class="cited-content_cbyCitation_article-title">Ru(
              ii
              )-Catalyzed and acidity-controlled tunable [5+1]/[5+2] annulation for building ring-fused quinazolines and 1,3-benzodiazepines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (76)
                                     , 11315-11318. <a href="https://doi.org/10.1039/D0CC04041J" title="DOI URL">https://doi.org/10.1039/D0CC04041J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC04041J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC04041J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DRu%252528%252Bii%252B%252529-Catalyzed%252Band%252Bacidity-controlled%252Btunable%252B%25255B5%25252B1%25255D%25252F%25255B5%25252B2%25255D%252Bannulation%252Bfor%252Bbuilding%252Bring-fused%252Bquinazolines%252Band%252B1%25252C3-benzodiazepines%26aulast%3DYang%26aufirst%3DYurong%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D76%26spage%3D11315%26epage%3D11318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren K.  Dobbs</span>, <span class="hlFld-ContribAuthor ">Hitoshi  Morikawa</span>. </span><span class="cited-content_cbyCitation_article-title">Biasing Neurotensin Receptor Signaling to Arrest Psychostimulant Abuse. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2020,</strong> <em>181 </em>
                                    (6)
                                     , 1205-1206. <a href="https://doi.org/10.1016/j.cell.2020.05.009" title="DOI URL">https://doi.org/10.1016/j.cell.2020.05.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2020.05.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2020.05.009%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DBiasing%252BNeurotensin%252BReceptor%252BSignaling%252Bto%252BArrest%252BPsychostimulant%252BAbuse%26aulast%3DDobbs%26aufirst%3DLauren%2BK.%26date%3D2020%26volume%3D181%26issue%3D6%26spage%3D1205%26epage%3D1206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lauren M.  Slosky</span>, <span class="hlFld-ContribAuthor ">Yushi  Bai</span>, <span class="hlFld-ContribAuthor ">Krisztian  Toth</span>, <span class="hlFld-ContribAuthor ">Caroline  Ray</span>, <span class="hlFld-ContribAuthor ">Lauren K.  Rochelle</span>, <span class="hlFld-ContribAuthor ">Alexandra  Badea</span>, <span class="hlFld-ContribAuthor ">Rahul  Chandrasekhar</span>, <span class="hlFld-ContribAuthor ">Vladimir M.  Pogorelov</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Abraham</span>, <span class="hlFld-ContribAuthor ">Namratha  Atluri</span>, <span class="hlFld-ContribAuthor ">Satyamaheshwar  Peddibhotla</span>, <span class="hlFld-ContribAuthor ">Michael P.  Hedrick</span>, <span class="hlFld-ContribAuthor ">Paul  Hershberger</span>, <span class="hlFld-ContribAuthor ">Patrick  Maloney</span>, <span class="hlFld-ContribAuthor ">Hong  Yuan</span>, <span class="hlFld-ContribAuthor ">Zibo  Li</span>, <span class="hlFld-ContribAuthor ">William C.  Wetsel</span>, <span class="hlFld-ContribAuthor ">Anthony B.  Pinkerton</span>, <span class="hlFld-ContribAuthor ">Lawrence S.  Barak</span>, <span class="hlFld-ContribAuthor ">Marc G.  Caron</span>. </span><span class="cited-content_cbyCitation_article-title">β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2020,</strong> <em>181 </em>
                                    (6)
                                     , 1364-1379.e14. <a href="https://doi.org/10.1016/j.cell.2020.04.053" title="DOI URL">https://doi.org/10.1016/j.cell.2020.04.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2020.04.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2020.04.053%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3D%2525CE%2525B2-Arrestin-Biased%252BAllosteric%252BModulator%252Bof%252BNTSR1%252BSelectively%252BAttenuates%252BAddictive%252BBehaviors%26aulast%3DSlosky%26aufirst%3DLauren%2BM.%26date%3D2020%26volume%3D181%26issue%3D6%26spage%3D1364%26epage%3D1379.e14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected previously reported NTR1 ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Quinazoline NTR1 modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Representative Synthesis of Quinazoline Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) (COCl)<sub>2</sub>, 35 °C, 1.5 h; (b) pyridine, DCM, rt, 2 h, 86% over 2 steps; (c) NaOH, H<sub>2</sub>O<sub>2</sub>, EtOH, reflux, 12 h, 66%; (d) K<sub>3</sub>PO<sub>4</sub>, CuI, proline, DMSO, 100 °C, 12 h; (e) NaBH(OAc)<sub>3</sub>, HCHO, MeOH, rt, 1 h, 39% over 2 steps; (f) BOP, DBU, CH<sub>3</sub>CN, rt, 12 h, 87%.</p></p></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Augmentation of [<sup>125</sup>I]-NT binding (0.02 nM) to cell membranes in the presence of increasing doses of <b>18</b> (SBI-553). The EC<sub>50</sub> for SBI-553 at the human receptor for this experiment was 0.14 μM, with a maximum efficacy of 140% (data were plotted and analyzed using GraphPad Prism v 7, <i>n</i> = 2). Efficacy is relative to the maximal displacement of orthosteric ligands (i.e., −100%). Data point excluded from curve fitting is shown in red. NT peptide in these assays give <i>K</i><sub>d</sub>s of 0.082 nM (hNTR1), 0.59 nM (hNTR2), and 0.17 nM (mNTR), respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Dose response of NT peptide in the presence of <b>18</b> (SBI-553) in the β-arrestin (A) and Ca<sup>2+</sup> flux (B) assays. Data were plotted and analyzed using GraphPad Prism v 7 and are presented as an average ± SEM (<i>n</i> = 4). The compound shows divergent behavior, with no effect on the EC<sub>50</sub> in the β-arrestin assay but a strong rightward shift in the Ca<sup>2+</sup> flux assay.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/medium/jm9b00340_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0017.jpeg" id="rightTab-GRAPHIC-d7e1551-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. <b>18</b> (SBI-553) attenuates basal hyperlocomotion in dopamine transporter knockout (DAT<sup>–/–</sup>) mice. Locomotor activity was evaluated using open field automated activity monitors (AccuScan Instruments, Columbus, OH). Male and female DAT<sup>–/–</sup> mice were acclimated to the open field chamber for 30 min prior to administration of NTR1 ligands (indicated by arrow). After treatment, animals were immediately returned to chambers and horizontal locomotion was monitored over the next 2 h. (A) Animals received SBI-553 (12 mg/kg), PD149163 (1 mg/kg), or vehicle (4% DMSO in saline; 10 mL/kg) ip. Beam breaks in 5 min intervals were recorded to generate horizontal distance traveled per time bin. *<i>p</i> < 0.05, <i>p</i> < 0.001 Vehicle vs SBI-553; #<i>p</i> < 0.05, <i>p</i> < 0.001 Vehicle vs PD149163; ∼<i>p</i> < 0.05, <i>p</i> < 0.001 SBI-553 vs PD149163, using a two-way, repeated measures ANOVA (<i>F</i><sub>Time</sub>(23,1679) = 13.5, <i>p</i> < 0.0001; <i>F</i><sub>Treatment</sub>(2,73) = 45.1, <i>p</i> < 0.0001; <i>F</i><sub>Interaction</sub>(46,1679) = 10.4, <i>p</i> < 0.0001) followed by the post hoc Tukey test. (B) Time course data in (A) was summed to determine the total distance traveled in the 2 h post-treatment. ***, ###, ∼∼∼ <i>p</i> < 0.001, as indicated, using one-way ANOVA (<i>F</i>(2,72) = 46.6, <i>p</i> < 0.0001) followed by the post hoc Tukey test. Data are represented as mean ± SEM of 18–29 animals per group. (C) Animals received SBI-553 10, 30, or 100 mg/kg or vehicle (distilled H<sub>2</sub>O) po. Beam breaks in 5 min intervals were recorded to generate horizontal distance traveled per time bin. *<i>p</i> < 0.05, <i>p</i> < 0.001 Vehicle vs 100 mg/kg SBI-553; #<i>p</i> < 0.05 Vehicle vs 30 mg/kg SBI-553; ∼<i>p</i> < 0.05 10 mg/kg SBI-553 vs 100 mg/kg SBI-553, using a two-way, repeated measures ANOVA (<i>F</i><sub>Time</sub>(23,989) = 8.6, <i>p</i> < 0.0001; <i>F</i><sub>Treatment</sub>(3,43) = 6.8, <i>p</i> < 0.001; <i>F</i><sub>Interaction</sub>(69,989) = 1.1, <i>p</i> = 0.2726) followed by the post hoc Tukey test. (D) Time course data in (C) was summed to determine the total distance traveled in the 2 h post-treatment. **<i>p</i> < 0.01, #<i>p</i> < 0.05, ∼<i>p</i> < 0.05, as indicated, using one-way ANOVA (<i>F</i>(3,43) = 6.8, <i>p</i> < 0.001) followed by the post hoc Tukey test. Data are represented as mean ± SEM of 11–12 animals per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-17/acs.jmedchem.9b00340/20190905/images/large/jm9b00340_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00340&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i26">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10728" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10728" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carraway, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeman, S. E.</span></span> <span> </span><span class="NLM_article-title">The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1973</span>,  <span class="NLM_volume"><i>248</i></span>,  <span class="NLM_fpage">6854</span>– <span class="NLM_lpage">6861</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=4745447" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaE2cXps1U%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1973&pages=6854-6861&author=R.+Carrawayauthor=S.+E.+Leeman&title=The+isolation+of+a+new+hypotensive+peptide%2C+neurotensin%2C+from+bovine+hypothalami"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami</span></div><div class="casAuthors">Carraway, Robert; Leeman, Susan E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">248</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6854-61</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    </div><div class="casAbstract">A hypotensive peptide, designated neurotensin, was isolated in pure form from acid-Me2CO exts. of bovine hypothalami by column chromatog. and paper electrophoresis.  Amino acid anal. of material recovered after paper electrophoresis at pH 3.5, 6.5, and 8.9 and chromatog. anal. of the dansylated material indicated that the peptide isolated by this procedure was homogenous.  Its amino acid compn. and apparent mol. wt. estd. by chromatog. on Sephadex G-25 indicated that neurotensin is a tridecapeptide composed of Lys, Arg2, Asx, Glx2, Pro2, Ileu, Leu2, Tyr2.  Neurotensin lacks a free N-terminus; however, it possesses a free C-terminus which can be acted upon by carboxypeptidase A.  Neurotensin induced hypotension in the rat and stimulated the contraction of guinea pig ileum and rat uterus; however, it produced relaxation of the rat duodenum.  These pharmacol. properties classify it as a kinin, yet its chem. compn. distinguishes it from any known peptide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGUMbGcmJyBrVg90H21EOLACvtfcHk0lhnhk48h5mPsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXps1U%253D&md5=717f2fac48338b8403ea764e6e59db00</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarraway%26aufirst%3DR.%26aulast%3DLeeman%26aufirst%3DS.%2BE.%26atitle%3DThe%2520isolation%2520of%2520a%2520new%2520hypotensive%2520peptide%252C%2520neurotensin%252C%2520from%2520bovine%2520hypothalami%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1973%26volume%3D248%26spage%3D6854%26epage%3D6861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uhl, G. R.</span></span> <span> </span><span class="NLM_article-title">Distribution of neurotensin and its receptor in the central nervous system</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>400</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.1982.tb31565.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1111%2Fj.1749-6632.1982.tb31565.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=6301323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A280%3ADyaL3s7ns1KnsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=1982&pages=132-149&author=G.+R.+Uhl&title=Distribution+of+neurotensin+and+its+receptor+in+the+central+nervous+system&doi=10.1111%2Fj.1749-6632.1982.tb31565.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of neurotensin and its receptor in the central nervous system</span></div><div class="casAuthors">Uhl G R</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-49</span>
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTTmvbmgdMnjrYtC3U5jeOifW6udTcc2eaQIB6ZtQaBKbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3s7ns1KnsA%253D%253D&md5=9b488a4ef90d9d0f57c2e6d8f091eb39</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1982.tb31565.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1982.tb31565.x%26sid%3Dliteratum%253Aachs%26aulast%3DUhl%26aufirst%3DG.%2BR.%26atitle%3DDistribution%2520of%2520neurotensin%2520and%2520its%2520receptor%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1982%26volume%3D400%26spage%3D132%26epage%3D149%26doi%3D10.1111%2Fj.1749-6632.1982.tb31565.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quirion, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowe, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lapchak, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araujo, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, A.</span></span> <span> </span><span class="NLM_article-title">Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems</span>. <i>Ann. N. Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>668</i></span>,  <span class="NLM_fpage">109</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.1992.tb27343.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1111%2Fj.1749-6632.1992.tb27343.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1361109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK3sXhtFOjs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=668&publication_year=1992&pages=109-119&author=R.+Quirionauthor=W.+B.+Roweauthor=P.+A.+Lapchakauthor=D.+M.+Araujoauthor=A.+Beaudet&title=Distribution+of+neurotensin+receptors+in+mammalian+brain.+What+it+is+telling+us+about+its+interactions+with+other+neurotransmitter+systems&doi=10.1111%2Fj.1749-6632.1992.tb27343.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Distribution of neurotensin receptors in mammalian brain.  What it is telling us about its interactions with other neurotransmitter systems</span></div><div class="casAuthors">Quirion, Remi; Rowe, Wayne B.; Lapchak, Paul A.; Araujo, Dalia M.; Beaudet, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">668</span>
        (<span class="NLM_cas:issue">Neurobiol. Neurotensin</span>),
    <span class="NLM_cas:pages">109-19</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    </div><div class="casAbstract">The localization of neurotensin receptors in the central nervous system is described.  Evidence is presented showing that neurotensin, by acting on specific receptors, modulates the activity of cholinergic and CRF-contg. neurons, besides dopaminergic neurons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqqjoqGereWbVg90H21EOLACvtfcHk0lgt2wNGB-7CUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhtFOjs7Y%253D&md5=86461b6824d933da61e6d23fc20e63c0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1992.tb27343.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1992.tb27343.x%26sid%3Dliteratum%253Aachs%26aulast%3DQuirion%26aufirst%3DR.%26aulast%3DRowe%26aufirst%3DW.%2BB.%26aulast%3DLapchak%26aufirst%3DP.%2BA.%26aulast%3DAraujo%26aufirst%3DD.%2BM.%26aulast%3DBeaudet%26aufirst%3DA.%26atitle%3DDistribution%2520of%2520neurotensin%2520receptors%2520in%2520mammalian%2520brain.%2520What%2520it%2520is%2520telling%2520us%2520about%2520its%2520interactions%2520with%2520other%2520neurotransmitter%2520systems%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1992%26volume%3D668%26spage%3D109%26epage%3D119%26doi%3D10.1111%2Fj.1749-6632.1992.tb27343.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span> <span> </span><span class="NLM_article-title">Neurotensin and neurotensin receptors</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">302</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1016/S0165-6147(99)01357-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2FS0165-6147%2899%2901357-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10390649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK1MXntlOmsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=302-309&author=J.-P.+Vincentauthor=J.+Mazellaauthor=P.+Kitabgi&title=Neurotensin+and+neurotensin+receptors&doi=10.1016%2FS0165-6147%2899%2901357-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin and neurotensin receptors</span></div><div class="casAuthors">Vincent, Jean-Pierre; Mazella, Jean; Kitabgi, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">302-309</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 67 refs.  Neurotensin is a brain and gastrointestinal peptide that fulfills many central and peripheral functions through its interaction with specific receptors.  Three subtypes of neurotensin receptors have been cloned.  Two of them belong to the family of G protein-coupled receptors, whereas the third one is an entirely new type of neuropeptide receptor and is identical to gp95/sortilin, a 100-kDa-protein with a single transmembrane domain.  In this review, the present knowledge regarding the mol. and pharmacol. properties of the three cloned neurotensin receptors is summarized and the relationship between these receptors and the known pharmacol. effects of neurotensin is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrCeY98U7pkbVg90H21EOLACvtfcHk0ljmd36326i1Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXntlOmsL8%253D&md5=b188fdab36656f4d2205fd411f0dc9fb</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0165-6147%2899%2901357-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-6147%252899%252901357-7%26sid%3Dliteratum%253Aachs%26aulast%3DVincent%26aufirst%3DJ.-P.%26aulast%3DMazella%26aufirst%3DJ.%26aulast%3DKitabgi%26aufirst%3DP.%26atitle%3DNeurotensin%2520and%2520neurotensin%2520receptors%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1999%26volume%3D20%26spage%3D302%26epage%3D309%26doi%3D10.1016%2FS0165-6147%2899%2901357-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hermans, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloteaux, J. M.</span></span> <span> </span><span class="NLM_article-title">Mechanisms of Regulation of Neurotensin Receptors</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">104</span>, <span class="refDoi"> DOI: 10.1016/S0163-7258(98)00009-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2FS0163-7258%2898%2900009-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=9749878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK1cXltVOktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1998&pages=89-104&author=E.+Hermansauthor=J.+M.+Maloteaux&title=Mechanisms+of+Regulation+of+Neurotensin+Receptors&doi=10.1016%2FS0163-7258%2898%2900009-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms of regulation of neurotensin receptors</span></div><div class="casAuthors">Hermans, Emmanuel; Maloteaux, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">89-104</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with ∼150 refs.  Since its discovery in 1973, the neuropeptide neurotensin has been demonstrated to be involved in the control of a broad variety of physiol. activities in both the central nervous system and in the periphery.  Pharmacol. studies have shown that the biol. effects elicited by neurotensin result from its specific binding to cell membrane neurotensin receptors that have been characterized in various tissue and in cell prepns.  In addn., it is now well documented that most of these responses are subject to rapid desensitization.  Such desensitization results in transient responses to sustained peptide applications, or to tachyphylaxis during successive stimulations in the same conditions.  More recently, desensitization of neurotensin signaling was investigated at the cellular and mol. levels.  In cultured cells, regulation at the second messenger level, receptor internalization, and receptor down-regulation processes have been reported.  These are proposed to play a crit. role in the control of cell responsiveness to neurotensin.  This review aims to compile recent data on the different biochem. processes involved in the regulation of the neurotensin receptor and to discuss the physiol. consequences of this regulation in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6GuGi4jfnrbVg90H21EOLACvtfcHk0li41eGVUxfUdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXltVOktrk%253D&md5=6b4e8c1c60e32b0fd8fe8161f77bed39</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900009-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900009-6%26sid%3Dliteratum%253Aachs%26aulast%3DHermans%26aufirst%3DE.%26aulast%3DMaloteaux%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520Regulation%2520of%2520Neurotensin%2520Receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D1998%26volume%3D79%26spage%3D89%26epage%3D104%26doi%3D10.1016%2FS0163-7258%2898%2900009-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nemeroff, C. B.</span></span> <span> </span><span class="NLM_article-title">The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia</span>. <i>Psychoneuroendocrinology</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">37</span>, <span class="refDoi"> DOI: 10.1016/0306-4530(86)90029-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2F0306-4530%2886%2990029-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=2871577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaL28XitVClu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1986&pages=15-37&author=C.+B.+Nemeroff&title=The+interaction+of+neurotensin+with+dopaminergic+pathways+in+the+central+nervous+system%3A+basic+neurobiology+and+implications+for+the+pathogenesis+and+treatment+of+schizophrenia&doi=10.1016%2F0306-4530%2886%2990029-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The interaction of neurotensin with dopaminergic pathways in the central nervous system:  basic neurobiology and implications for the pathogenesis and treatment of schizophrenia</span></div><div class="casAuthors">Nemeroff, Charles B.</div><div class="citationInfo"><span class="NLM_cas:title">Psychoneuroendocrinology</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">15-37</span>CODEN:
                <span class="NLM_cas:coden">PSYCDE</span>;
        ISSN:<span class="NLM_cas:issn">0306-4530</span>.
    </div><div class="casAbstract">A review with 98 refs.  The neurochem., neuroanatomical, and behavioral evidence that have led to the hypothesis that neurotensin is an important endogenous modulator of the activity of dopaminergic systems in the mammalian central nervous system is presented.  The implications of the hypothesis for the etiol., pathogenesis, and treatment of major psychotic disorders, esp. schizophrenia is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp10XNHTSZn7rVg90H21EOLACvtfcHk0li41eGVUxfUdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XitVClu74%253D&md5=ec76d824e3090274c9d126bc3463cd5c</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2F0306-4530%2886%2990029-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-4530%252886%252990029-6%26sid%3Dliteratum%253Aachs%26aulast%3DNemeroff%26aufirst%3DC.%2BB.%26atitle%3DThe%2520interaction%2520of%2520neurotensin%2520with%2520dopaminergic%2520pathways%2520in%2520the%2520central%2520nervous%2520system%253A%2520basic%2520neurobiology%2520and%2520implications%2520for%2520the%2520pathogenesis%2520and%2520treatment%2520of%2520schizophrenia%26jtitle%3DPsychoneuroendocrinology%26date%3D1986%26volume%3D11%26spage%3D15%26epage%3D37%26doi%3D10.1016%2F0306-4530%2886%2990029-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schimpff, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenelon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lhiaubet, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tenneze, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidailhet, M.</span></span> <span> </span><span class="NLM_article-title">Increased plasma neurotensin concentrations in patients with Parkinson’s disease</span>. <i>J. Neurol., Neurosurg. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1136/jnnp.70.6.784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1136%2Fjnnp.70.6.784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=11385014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A280%3ADC%252BD3Mzht1Sjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2001&pages=784-786&author=R.+M.+Schimpffauthor=C.+Avardauthor=G.+Fenelonauthor=A.+M.+Lhiaubetauthor=L.+Tennezeauthor=M.+Vidailhet&title=Increased+plasma+neurotensin+concentrations+in+patients+with+Parkinson%E2%80%99s+disease&doi=10.1136%2Fjnnp.70.6.784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Increased plasma neurotensin concentrations in patients with Parkinson's disease</span></div><div class="casAuthors">Schimpff R M; Avard C; Fenelon G; Lhiaubet A M; Tenneze L; Vidailhet M; Rostene W</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neurology, neurosurgery, and psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">784-6</span>
        ISSN:<span class="NLM_cas:issn">0022-3050</span>.
    </div><div class="casAbstract">Plasma neurotensin (NT) was measured by radioimmunoassay in propanol extracted and unextracted plasma from 16 parkinsonian patients (four before treatment) and 16 age and sex matched controls.  Mean plasma NT concentrations were consistently higher in parkinsonian patients than in controls and higher in the four untreated patients than in levodopa treated patients suggesting that plasma NT measurement may represent an easy detectable additional index in diagnosing parkinsonism and provides a novel approach to research in this field.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSfKosPxJtsNDUE-swuRqsHfW6udTcc2eb__r8uEfdrFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3Mzht1Sjtg%253D%253D&md5=ffe531137c2f920daa88b39e7779b190</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1136%2Fjnnp.70.6.784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fjnnp.70.6.784%26sid%3Dliteratum%253Aachs%26aulast%3DSchimpff%26aufirst%3DR.%2BM.%26aulast%3DAvard%26aufirst%3DC.%26aulast%3DFenelon%26aufirst%3DG.%26aulast%3DLhiaubet%26aufirst%3DA.%2BM.%26aulast%3DTenneze%26aufirst%3DL.%26aulast%3DVidailhet%26aufirst%3DM.%26atitle%3DIncreased%2520plasma%2520neurotensin%2520concentrations%2520in%2520patients%2520with%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%252C%2520Neurosurg.%2520Psychiatry%26date%3D2001%26volume%3D70%26spage%3D784%26epage%3D786%26doi%3D10.1136%2Fjnnp.70.6.784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredrickson, P.</span></span> <span> </span><span class="NLM_article-title">Neurotensin agonists: possible drugs for treatment of psychostimulant abuse</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>73</i></span>,  <span class="NLM_fpage">679</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1016/S0024-3205(03)00388-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2FS0024-3205%2803%2900388-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=12801589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVehtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2003&pages=679-690&author=E.+Richelsonauthor=M.+Boulesauthor=P.+Fredrickson&title=Neurotensin+agonists%3A+possible+drugs+for+treatment+of+psychostimulant+abuse&doi=10.1016%2FS0024-3205%2803%2900388-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotensin agonists: possible drugs for treatment of psychostimulant abuse</span></div><div class="casAuthors">Richelson, Elliott; Boules, Mona; Fredrickson, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">679-690</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review.  Although many neuropeptides have been implicated in the pathophysiol. of psychostimulant abuse, the tridecapeptide neurotensin holds a prominent position in this field due to the compelling literature on this peptide and psychostimulants.  These data strongly support the hypothesis that a neurotensin agonist will be clin. useful to treat the abuse of psychostimulants, including nicotine.  This paper reviews the evidence for a role for neurotensin in stimulant abuse and for a neurotensin agonist for its treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6EiJ-scKBwrVg90H21EOLACvtfcHk0liSjP-7mXRkJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVehtL4%253D&md5=4f034616a14545612ed509dd670bec7a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0024-3205%2803%2900388-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0024-3205%252803%252900388-6%26sid%3Dliteratum%253Aachs%26aulast%3DRichelson%26aufirst%3DE.%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DFredrickson%26aufirst%3DP.%26atitle%3DNeurotensin%2520agonists%253A%2520possible%2520drugs%2520for%2520treatment%2520of%2520psychostimulant%2520abuse%26jtitle%3DLife%2520Sci.%26date%3D2003%26volume%3D73%26spage%3D679%26epage%3D690%26doi%3D10.1016%2FS0024-3205%2803%2900388-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boules, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredrickson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richelson, E.</span></span> <span> </span><span class="NLM_article-title">Diverse Roles of Neurotensin Agonists in the Central Nervous System Front</span>. <i>Front. Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">36</span>, <span class="refDoi"> DOI: 10.3389/fendo.2013.00036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.3389%2Ffendo.2013.00036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=23526754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A280%3ADC%252BC3svptlGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=36&author=M.+Boulesauthor=Z.+Liauthor=K.+Smithauthor=P.+Fredricksonauthor=E.+Richelson&title=Diverse+Roles+of+Neurotensin+Agonists+in+the+Central+Nervous+System+Front&doi=10.3389%2Ffendo.2013.00036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse roles of neurotensin agonists in the central nervous system</span></div><div class="casAuthors">Boules Mona; Li Zhimin; Smith Kristin; Fredrickson Paul; Richelson Elliott</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in endocrinology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36</span>
        ISSN:<span class="NLM_cas:issn">1664-2392</span>.
    </div><div class="casAbstract">Neurotensin (NT) is a tridecapeptide that is found in the central nervous system (CNS) and the gastrointestinal tract.  NT behaves as a neurotransmitter in the brain and as a hormone in the gut.  Additionally, NT acts as a neuromodulator to several neurotransmitter systems including dopaminergic, sertonergic, GABAergic, glutamatergic, and cholinergic systems.  Due to its association with such a wide variety of neurotransmitters, NT has been implicated in the pathophysiology of several CNS disorders such as schizophrenia, drug abuse, Parkinson's disease (PD), pain, central control of blood pressure, eating disorders, as well as, cancer and inflammation.  The present review will focus on the role that NT and its analogs play in schizophrenia, endocrine function, pain, psychostimulant abuse, and PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRRFnBUpHYR8fIW7hznt0zpfW6udTcc2eaKj2r2xEin1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svptlGisw%253D%253D&md5=1d8b45188dddd238b0783c9564fffd16</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffendo.2013.00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffendo.2013.00036%26sid%3Dliteratum%253Aachs%26aulast%3DBoules%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DSmith%26aufirst%3DK.%26aulast%3DFredrickson%26aufirst%3DP.%26aulast%3DRichelson%26aufirst%3DE.%26atitle%3DDiverse%2520Roles%2520of%2520Neurotensin%2520Agonists%2520in%2520the%2520Central%2520Nervous%2520System%2520Front%26jtitle%3DFront.%2520Endocrinol.%26date%3D2013%26volume%3D4%26spage%3D36%26doi%3D10.3389%2Ffendo.2013.00036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">White, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noinaj, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gvozdenovic-Jeremic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiloach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grisshammer, R.</span></span> <span> </span><span class="NLM_article-title">Structure of the agonist-bound neurotensin receptor</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>490</i></span>,  <span class="NLM_fpage">508</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1038/nature11558</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1038%2Fnature11558" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=23051748" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVykt7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=490&publication_year=2012&pages=508-513&author=J.+F.+Whiteauthor=N.+Noinajauthor=Y.+Shibataauthor=J.+Loveauthor=B.+Klossauthor=F.+Xuauthor=J.+Gvozdenovic-Jeremicauthor=P.+Shahauthor=J.+Shiloachauthor=C.+G.+Tateauthor=R.+Grisshammer&title=Structure+of+the+agonist-bound+neurotensin+receptor&doi=10.1038%2Fnature11558"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the agonist-bound neurotensin receptor</span></div><div class="casAuthors">White, Jim F.; Noinaj, Nicholas; Shibata, Yoko; Love, James; Kloss, Brian; Xu, Feng; Gvozdenovic-Jeremic, Jelena; Shah, Priyanka; Shiloach, Joseph; Tate, Christopher G.; Grisshammer, Reinhard</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">490</span>
        (<span class="NLM_cas:issue">7421</span>),
    <span class="NLM_cas:pages">508-513</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Neurotensin (NTS) is a 13-amino-acid peptide that functions as both a neurotransmitter and a hormone through the activation of the neurotensin receptor NTSR1, a G-protein-coupled receptor (GPCR).  In the brain, NTS modulates the activity of dopaminergic systems, opioid-independent analgesia, and the inhibition of food intake; in the gut, NTS regulates a range of digestive processes.  Here we present the structure at 2.8 Å resoln. of Rattus norvegicus NTSR1 in an active-like state, bound to NTS8-13, the carboxy-terminal portion of NTS responsible for agonist-induced activation of the receptor.  The peptide agonist binds to NTSR1 in an extended conformation nearly perpendicular to the membrane plane, with the C terminus oriented towards the receptor core.  Our findings provide, to our knowledge, the first insight into the binding mode of a peptide agonist to a GPCR and may support the development of non-peptide ligands that could be useful in the treatment of neurol. disorders, cancer and obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMGexg96PiObVg90H21EOLACvtfcHk0lg-lq-svvMBOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVykt7%252FP&md5=c55a071640dec7edae7a69d715bea675</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnature11558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11558%26sid%3Dliteratum%253Aachs%26aulast%3DWhite%26aufirst%3DJ.%2BF.%26aulast%3DNoinaj%26aufirst%3DN.%26aulast%3DShibata%26aufirst%3DY.%26aulast%3DLove%26aufirst%3DJ.%26aulast%3DKloss%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DF.%26aulast%3DGvozdenovic-Jeremic%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DShiloach%26aufirst%3DJ.%26aulast%3DTate%26aufirst%3DC.%2BG.%26aulast%3DGrisshammer%26aufirst%3DR.%26atitle%3DStructure%2520of%2520the%2520agonist-bound%2520neurotensin%2520receptor%26jtitle%3DNature%26date%3D2012%26volume%3D490%26spage%3D508%26epage%3D513%26doi%3D10.1038%2Fnature11558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Egloff, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillenbrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klenk, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batyuk, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlinkmann, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schütz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plückthun, A.</span></span> <span> </span><span class="NLM_article-title">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">E655</span>– <span class="NLM_lpage">E662</span>, <span class="refDoi"> DOI: 10.1073/pnas.1317903111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1073%2Fpnas.1317903111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=24453215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=E655-E662&issue=6&author=P.+Egloffauthor=M.+Hillenbrandauthor=C.+Klenkauthor=A.+Batyukauthor=P.+Heineauthor=S.+Baladaauthor=K.+M.+Schlinkmannauthor=D.+J.+Scottauthor=M.+Sch%C3%BCtzauthor=A.+Pl%C3%BCckthun&title=Structure+of+signaling-competent+neurotensin+receptor+1+obtained+by+directed+evolution+in+Escherichia+coli&doi=10.1073%2Fpnas.1317903111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli</span></div><div class="casAuthors">Egloff, Pascal; Hillenbrand, Matthias; Klenk, Christoph; Batyuk, Alexander; Heine, Philipp; Balada, Stefanie; Schlinkmann, Karola M.; Scott, Daniel J.; Schutz, Marco; Pluckthun, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">E655-E662</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Crystallog. has advanced our understanding of G protein-coupled receptors, but low expression levels and instability in soln. have limited structural insights to very few selected members of this large protein family.  Using neurotensin receptor 1 (NTR1) as a proof of principle, we show that two directed evolution technologies that we recently developed have the potential to overcome these problems.  We purified three neurotensin-bound NTR1 variants from Escherichia coli and detd. their x-ray structures at up to 2.75 Å resoln. using vapor diffusion crystn. expts.  A crystd. construct was pharmacol. characterized and exhibited ligand-dependent signaling, internalization, and wild-type-like agonist and antagonist affinities.  Our structures are fully consistent with all biochem. defined ligand-contacting residues, and they represent an inactive NTR1 state at the cytosolic side.  They exhibit significant differences to a previously detd. NTR1 structure (Protein Data Bank ID code 4GRV) in the ligand-binding pocket and by the presence of the amphipathic helix 8.  A comparison of helix 8 stability determinants between NTR1 and other crystd. G protein-coupled receptors suggests that the occupancy of the canonical position of the amphipathic helix is reduced to various extents in many receptors, and we have elucidated the sequence determinants for a stable helix 8.  Our anal. also provides a structural rationale for the long-known effects of C-terminal palmitoylation reactions on G protein-coupled receptor signaling, receptor maturation, and desensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEqfddVgyHFLVg90H21EOLACvtfcHk0lgullMjADThcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOntrc%253D&md5=036230389cacc05a6462cf7b6a55278b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1317903111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1317903111%26sid%3Dliteratum%253Aachs%26aulast%3DEgloff%26aufirst%3DP.%26aulast%3DHillenbrand%26aufirst%3DM.%26aulast%3DKlenk%26aufirst%3DC.%26aulast%3DBatyuk%26aufirst%3DA.%26aulast%3DHeine%26aufirst%3DP.%26aulast%3DBalada%26aufirst%3DS.%26aulast%3DSchlinkmann%26aufirst%3DK.%2BM.%26aulast%3DScott%26aufirst%3DD.%2BJ.%26aulast%3DSch%25C3%25BCtz%26aufirst%3DM.%26aulast%3DPl%25C3%25BCckthun%26aufirst%3DA.%26atitle%3DStructure%2520of%2520signaling-competent%2520neurotensin%2520receptor%25201%2520obtained%2520by%2520directed%2520evolution%2520in%2520Escherichia%2520coli%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26issue%3D6%26spage%3DE655%26epage%3DE662%26doi%3D10.1073%2Fpnas.1317903111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griebel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holsboer, F.</span></span> <span> </span><span class="NLM_article-title">Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">462</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1038/nrd3702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1038%2Fnrd3702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=22596253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC38XntFyru70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=462-478&author=G.+Griebelauthor=F.+Holsboer&title=Neuropeptide+receptor+ligands+as+drugs+for+psychiatric+diseases%3A+the+end+of+the+beginning%3F&doi=10.1038%2Fnrd3702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?</span></div><div class="casAuthors">Griebel, Guy; Holsboer, Florian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">462-478</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The search for novel drugs for treating psychiatric disorders is driven by the growing medical need to improve on the effectiveness and side-effect profile of currently available therapies.  Given the wealth of preclin. data supporting the role of neuropeptides in modulating behavior, pharmaceutical companies have been attempting to target neuropeptide receptors for over two decades.  However, clin. studies with synthetic neuropeptide ligands have been unable to confirm the promise predicted by studies in animal models.  Here, we analyze preclin. and clin. results for neuropeptide receptor ligands that have been studied in clin. trials for psychiatric diseases, including agents that target the receptors for tachykinins, corticotropin-releasing factor, vasopressin and neurotensin, and suggest new ways to exploit the full potential of these candidate drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAyxMYykGx07Vg90H21EOLACvtfcHk0liVbWa9PiG7Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntFyru70%253D&md5=b9aaf2b537fb73cac78d0654f0c80ed9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnrd3702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3702%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DHolsboer%26aufirst%3DF.%26atitle%3DNeuropeptide%2520receptor%2520ligands%2520as%2520drugs%2520for%2520psychiatric%2520diseases%253A%2520the%2520end%2520of%2520the%2520beginning%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D462%26epage%3D478%26doi%3D10.1038%2Fnrd3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hadden, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwig, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokko, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazella, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dix, T. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8–13) analogues containing non-natural arginine and lysine residues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1159</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.neuropharm.2005.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=16095636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1ejs77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1149-1159&author=M.+K.+Haddenauthor=K.+S.+Orwigauthor=K.+P.+Kokkoauthor=J.+Mazellaauthor=T.+A.+Dix&title=Design%2C+synthesis%2C+and+evaluation+of+the+antipsychotic+potential+of+orally+bioavailable+neurotensin+%288%E2%80%9313%29+analogues+containing+non-natural+arginine+and+lysine+residues&doi=10.1016%2Fj.neuropharm.2005.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues</span></div><div class="casAuthors">Hadden, M. Kyle; Orwig, Kevin S.; Kokko, Kyle P.; Mazella, Jean; Dix, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1149-1159</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotensin (NT) and its active fragment NT(8-13) elicit behavioral responses typical of clin. used antipsychotic drugs when administered directly to the brain.  However, limited peptide stability and oral bioavailability have prevented these compds. from being developed as relevant pharmaceuticals.  Recently, our lab. designed and studied a first-generation NT(8-13) deriv., KK13, that elicited key pharmacokinetic and behavioral responses typical of clin. used antipsychotic drugs when administered to rats parenterally.  This compd. was the basis for the rational design of a series of second-generation NT(8-13) analogs (KH1-KH30) studied in this paper.  Initial screening of these analogs for CNS activity by monitoring hypothermia induction after peripheral administration defined several compds. (KH11, KH24, KH26, and KH28-KH30) that warranted further investigation.  Each compd. maintained binding affinity for NTR1, however, only KH24, KH26, and KH28 (as well as KK13) elicited significant hypothermic responses after oral administration.  Of these, KH28 demonstrated an oral activity 3-fold greater than any other analog; hence it was further characterized in a series of rat behavioral assays.  KH28 attenuated D-amphetamine induced hyperlocomotion, a hallmark of current clin. effective antipsychotic drugs, after both IP and oral administration.  In addn., tolerance to the compd. did not develop after repeated daily dosing, as measured by hypothermic induction as well as attenuation of D-amphetamine induced hyperlocomotion.  Finally, KH28 did not produce catalepsy, a deleterious side-effect elicited by classical antipsychotic drugs.  KH28 is considered to be an ideal compd. for further development as a potential novel antipsychotic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmjBoV7ura1bVg90H21EOLACvtfcHk0liVbWa9PiG7Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1ejs77I&md5=4bcc22660bda0140c9bfdfbd722c4ddf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DHadden%26aufirst%3DM.%2BK.%26aulast%3DOrwig%26aufirst%3DK.%2BS.%26aulast%3DKokko%26aufirst%3DK.%2BP.%26aulast%3DMazella%26aufirst%3DJ.%26aulast%3DDix%26aufirst%3DT.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520the%2520antipsychotic%2520potential%2520of%2520orally%2520bioavailable%2520neurotensin%2520%25288%25E2%2580%259313%2529%2520analogues%2520containing%2520non-natural%2520arginine%2520and%2520lysine%2520residues%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D1149%26epage%3D1159%26doi%3D10.1016%2Fj.neuropharm.2005.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boigegrain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeanjean, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molimard, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poncelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gueudet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heaulme, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leyris, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brouard, A.</span></span> <span> </span><span class="NLM_article-title">Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">65</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1073/pnas.90.1.65</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1073%2Fpnas.90.1.65" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=8380498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK3sXhs1Srurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1993&pages=65-69&author=D.+Gullyauthor=M.+Cantonauthor=R.+Boigegrainauthor=F.+Jeanjeanauthor=J.+C.+Molimardauthor=M.+Ponceletauthor=C.+Gueudetauthor=M.+Heaulmeauthor=R.+Leyrisauthor=A.+Brouard&title=Biochemical+and+pharmacological+profile+of+a+potent+and+selective+nonpeptide+antagonist+of+the+neurotensin+receptor&doi=10.1073%2Fpnas.90.1.65"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor</span></div><div class="casAuthors">Gully, Danielle; Canton, Maryse; Boigegrain, Robert; Jeanjean, Francis; Molimard, Jean Charles; Poncelet, Martine; Gueudet, Christiane; Heaulme, Michel; Leyris, Roger; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65-9</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">We describe the characteristics of SR 48692 (I), a selective, nonpeptide antagonist of the neurotensin receptor.  In vitro, this compd. competitively inhibits 125I-labeled neurotensin binding to the high-affinity binding site present in brain tissue from various species with IC50 values of 0.99 nM (guinea pig), 4.0 nM (rat mesencephalic cells), 7.6 nM (COS-7 cells transfected with the cloned high-affinity rat brain receptor), 13.7 nM (newborn mouse brain), 17.8 nM (newborn human brain), 8.7 nM (adult human brain), and 30.3 nM (HT-29 cells).  It also displaces 125I-labeled neurotensin from the low-affinity levocabastine-sensitive binding sites but at higher concns. (34.8 nM for adult mouse brain and 82.0 nM for adult rat brain).  In guinea pig striatal slices, SR 48692 blocks K+-evoked release of [3H]dopamine stimulated by neurotensin with a potency (IC50 = 0.46 nM) that correlates with its binding affinity.  In a cell line derived from a human colon carcinoma (HT-29), SR 48692 competitively antagonizes neurotensin-induced intracellular Ca2+ mobilization with a pA2 (-log K3app) values of 8.13, which is consistent with results obtained in binding studies.  Moreover, SR 48692 is devoid of any intrinsic agonist activity.  This compd. is also active in vivo, since it reverses at low dose (80 μg/kg) the turning behavior induced by intrastriatal injection of neurotensin in mice with similar potency whatever the route of administration (i.p. or orally) and with a long duration of action (6 h).  Thus, being a potent and selective neurotensin receptor antagonist, SR 48692 may be considered as a powerful tool for investigating the role of neurotensin in physiol. and pathol. processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9FBuoak0ov7Vg90H21EOLACvtfcHk0liLXMevuhCjrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhs1Srurk%253D&md5=89cfbc973e5cce0e7af8d14f943c98f6</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.90.1.65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.90.1.65%26sid%3Dliteratum%253Aachs%26aulast%3DGully%26aufirst%3DD.%26aulast%3DCanton%26aufirst%3DM.%26aulast%3DBoigegrain%26aufirst%3DR.%26aulast%3DJeanjean%26aufirst%3DF.%26aulast%3DMolimard%26aufirst%3DJ.%2BC.%26aulast%3DPoncelet%26aufirst%3DM.%26aulast%3DGueudet%26aufirst%3DC.%26aulast%3DHeaulme%26aufirst%3DM.%26aulast%3DLeyris%26aufirst%3DR.%26aulast%3DBrouard%26aufirst%3DA.%26atitle%3DBiochemical%2520and%2520pharmacological%2520profile%2520of%2520a%2520potent%2520and%2520selective%2520nonpeptide%2520antagonist%2520of%2520the%2520neurotensin%2520receptor%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1993%26volume%3D90%26spage%3D65%26epage%3D69%26doi%3D10.1073%2Fpnas.90.1.65" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeeuw, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boigegrain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oury-Donat, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bachy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poncelet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suaud-Chagny, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vita, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pecceu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labbe- Jullie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitabgi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soubrie, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Fur, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffrand, J. P.</span></span> <span> </span><span class="NLM_article-title">Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">802</span>– <span class="NLM_lpage">812</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=9023294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK2sXivVWkurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1997&pages=802-812&author=D.+Gullyauthor=B.+Labeeuwauthor=R.+Boigegrainauthor=F.+Oury-Donatauthor=A.+Bachyauthor=M.+Ponceletauthor=R.+Steinbergauthor=M.+F.+Suaud-Chagnyauthor=V.+Santucciauthor=N.+Vitaauthor=F.+Pecceuauthor=C.+Labbe-+Jullieauthor=P.+Kitabgiauthor=P.+Soubrieauthor=G.+Le+Furauthor=J.+P.+Maffrand&title=Biochemical+and+pharmacological+activities+of+SR+142948A%2C+a+new+potent+neurotensin+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist</span></div><div class="casAuthors">Gully, Danielle; Labeeuw, Bernard; Biogegrain, Robert; Oury-Donat, Florence; Bachy, Andre; Poncelet, Martine; Steinberg, Regis; Suaud-Chagny, Marie Francoise; Santucci, Vincent; Vita, Natalio; Pecceu, Florence; Labbe-Jullie, Catherine; Kitabgi, Patrick; Soubrie, Philippe; Le Fur, Gerard; Maffrand, Jean Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">802-812</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">SR 142948A, 2-{[5-(2,6-dimethoxyphenyl)-1-(4-(N-(3-dimethylaminopropyl)-N-methylcarbamoyl)-2-isopropylphenyl)-1H-pyrazole-3-carbonyl]amino}adamantane-2-carboxylic acid, hydrochloride, a new and extremely potent neurotensin (NT) receptor antagonist, has been characterized in comparison with SR 48692.  This selective compd. possesses nanomolar affinities for NT receptors, recognizes the two binding sites described for the NT receptor and fully displaces [3H]Sr 48692 specific binding.  SR 142948A antagonizes the classical in vitro NT effects, i.e.l, inositol monophosphate formation in HT 29 cells (IC50 = 3.9 nM) or intracellular calcium mobilization in Chinese hamster ovary cells transfected with the human receptor.  It dose-dependently (0.04-640×10-3 mg./kg p.o.) inhibits the turning behavior induced by unilateral intrastriatal injection of NT in mice, with the biphasic profile previously seen for SR 48692.  At 0.1 mg/kg (i.p.), it completely antagonizes NT-evoked acetylcholine release in the rat striatum.  In contrast to SR 48692, SR 142948A (p.o.) blocks both hypothermia and analgesia induced by i.c.v. injection of NT (mice and/or rats) but is unable to modify the dopamine release evoked by NT injection into the central tegmental area.  In summary, SR 142948A retains the properties of the lead compd. SR 48692 (no intrinsic agonist activity, oral bioavailability, long duration of action and good brain access), reveals a wider spectrum of activity than SR 48692 (probably due to the inhibition of NT receptor subtypes) and represents an addnl. tool for further exploration of the therapeutic potential of this class of compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpycUQVvgjnErVg90H21EOLACvtfcHk0liWsvwDmjYSzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXivVWkurk%253D&md5=30218d6e53cc7bd8ab180657116ab7df</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGully%26aufirst%3DD.%26aulast%3DLabeeuw%26aufirst%3DB.%26aulast%3DBoigegrain%26aufirst%3DR.%26aulast%3DOury-Donat%26aufirst%3DF.%26aulast%3DBachy%26aufirst%3DA.%26aulast%3DPoncelet%26aufirst%3DM.%26aulast%3DSteinberg%26aufirst%3DR.%26aulast%3DSuaud-Chagny%26aufirst%3DM.%2BF.%26aulast%3DSantucci%26aufirst%3DV.%26aulast%3DVita%26aufirst%3DN.%26aulast%3DPecceu%26aufirst%3DF.%26aulast%3DLabbe-%2BJullie%26aufirst%3DC.%26aulast%3DKitabgi%26aufirst%3DP.%26aulast%3DSoubrie%26aufirst%3DP.%26aulast%3DLe%2BFur%26aufirst%3DG.%26aulast%3DMaffrand%26aufirst%3DJ.%2BP.%26atitle%3DBiochemical%2520and%2520pharmacological%2520activities%2520of%2520SR%2520142948A%252C%2520a%2520new%2520potent%2520neurotensin%2520receptor%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D280%26spage%3D802%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmour, B.</span></span> <span> </span><span class="NLM_article-title">The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1438</span>– <span class="NLM_lpage">1441</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.bmcl.2009.01.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=19195889" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wmsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1438-1441&author=J.+B.+Thomasauthor=H.+Navarroauthor=K.+R.+Warnerauthor=B.+Gilmour&title=The+identification+of+nonpeptide+neurotensin+receptor+partial+agonists+from+the+potent+antagonist+SR48692+using+a+calcium+mobilization+assay&doi=10.1016%2Fj.bmcl.2009.01.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of nonpeptide neurotensin receptor partial agonists from the potent antagonist SR48692 using a calcium mobilization assay</span></div><div class="casAuthors">Thomas, James B.; Navarro, Hernan; Warner, Keith R.; Gilmour, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1438-1441</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In a search for nonpeptide agonists for the neurotensin receptor (NTR1), we replaced the adamantyl amino acid moiety found in the antagonist SR48692 (1a) with leucine and related α-alkylamino acids found in peptide agonists.  When tested in a calcium mobilization assay, we found that both - and -leucine confer partial agonist activity to the pyrazole scaffold with the -enantiomer (3a) providing a significantly greater response.  A brief SAR survey demonstrated that the obsd. agonist activity was resilient to changes made to the dimethoxyaryl ring in 3a.  The resulting compds. were less potent relative to 3a but showed greater agonist responses.  The partial agonist activity was extinguished when the chloroquinoline ring was replaced with naphthalene.  Thus, while L-leucine appears to possess a powerful agonist directing affect for the NTR1 receptor, its presence alone in the mol. architecture is not sufficient to insure agonist behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrB3thhb1eSV7Vg90H21EOLACvtfcHk0lioubPPWk34qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wmsbs%253D&md5=c74adc0e9bd526a5f36c206306fc5f4d</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DNavarro%26aufirst%3DH.%26aulast%3DWarner%26aufirst%3DK.%2BR.%26aulast%3DGilmour%26aufirst%3DB.%26atitle%3DThe%2520identification%2520of%2520nonpeptide%2520neurotensin%2520receptor%2520partial%2520agonists%2520from%2520the%2520potent%2520antagonist%2520SR48692%2520using%2520a%2520calcium%2520mobilization%2520assay%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1438%26epage%3D1441%26doi%3D10.1016%2Fj.bmcl.2009.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peddibhotla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangravita- Novo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosalia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicchiarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barak, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, G. P.</span></span> <span> </span><span class="NLM_article-title">Imidazole-derived agonists for the neurotensin 1 receptor</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">262</span>– <span class="NLM_lpage">267</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.bmcl.2013.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=24332089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFOrurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=262-267&author=P.+M.+Hershbergerauthor=M.+P.+Hedrickauthor=S.+Peddibhotlaauthor=A.+Mangravita-+Novoauthor=P.+Gosaliaauthor=Y.+Liauthor=W.+Grayauthor=M.+Vicchiarelliauthor=L.+H.+Smithauthor=T.+D.+Chungauthor=J.+B.+Thomasauthor=M.+G.+Caronauthor=A.+B.+Pinkertonauthor=L.+S.+Barakauthor=G.+P.+Roth&title=Imidazole-derived+agonists+for+the+neurotensin+1+receptor&doi=10.1016%2Fj.bmcl.2013.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazole-derived agonists for the neurotensin 1 receptor</span></div><div class="casAuthors">Hershberger, Paul M.; Hedrick, Michael P.; Peddibhotla, Satyamaheshwar; Mangravita-Novo, Arianna; Gosalia, Palak; Li, Yujie; Gray, Wilson; Vicchiarelli, Michael; Smith, Layton H.; Chung, Thomas D. Y.; Thomas, James B.; Caron, Marc G.; Pinkerton, Anthony B.; Barak, Lawrence S.; Roth, Gregory P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">262-267</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A scaffold-hop program seeking full agonists of the neurotensin-1 (NTR1) receptor identified the probe mol. ML301 (1) and assocd. analogs, including its naphthyl analog (14) which exhibited similar properties.  Compd. 1 showed full agonist behavior (79-93%) with an EC50 of 2.0-4.1 μM against NTR1.  Compd. 1 also showed good activity in a Ca mobilization FLIPR assay (93% efficacy at 298 nM), consistent with it functioning via the Gq coupled pathway, and good selectivity relative to NTR2 and GPR35.  In further profiling, 1 showed low potential for promiscuity and good overall pharmacol. data.  This report describes the discovery, synthesis, and SAR of 1 and assocd. analogs.  Initial in vitro pharmacol. characterization is also presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwenmL-YqLj7Vg90H21EOLACvtfcHk0lj1kwDoghOf0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFOrurjI&md5=eea781b7c7e912f85cddec433a2fe557</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DHershberger%26aufirst%3DP.%2BM.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DPeddibhotla%26aufirst%3DS.%26aulast%3DMangravita-%2BNovo%26aufirst%3DA.%26aulast%3DGosalia%26aufirst%3DP.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DW.%26aulast%3DVicchiarelli%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DL.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26atitle%3DImidazole-derived%2520agonists%2520for%2520the%2520neurotensin%25201%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D262%26epage%3D267%26doi%3D10.1016%2Fj.bmcl.2013.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andree, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dollings, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pausch, M. H.</span></span> <span> </span><span class="NLM_article-title">The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5789</span>– <span class="NLM_lpage">5791</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2008.09.075</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.bmcl.2008.09.075" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=18849166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht12rs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=5789-5791&author=Y.+Fanauthor=M.+H.+Laiauthor=K.+Sullivanauthor=M.+Popiolekauthor=T.+H.+Andreeauthor=P.+Dollingsauthor=M.+H.+Pausch&title=The+identification+of+neurotensin+NTS1+receptor+partial+agonists+through+a+ligand-based+virtual+screening+approach&doi=10.1016%2Fj.bmcl.2008.09.075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The identification of neurotensin NTS1 receptor partial agonists through a ligand-based virtual screening approach</span></div><div class="casAuthors">Fan, Yi; Lai, Margaret H.; Sullivan, Kelly; Popiolek, Michael; Andree, Terrance H.; Dollings, Paul; Pausch, Mark H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">5789-5791</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">We identified small mol. NTS1R agonist compds. through virtual screening of the corporate database using a ROCS approach that searches multi-conformer representations efficiently.  As a starting point for the ROCS search, we used the known NTS1R selective antagonist, SR-48527, based on the hypothesis that NT agonists and antagonists might share similar binding regions.  Conformations were expanded and selected as database search queries based on a cluster anal.  The search provided us with virtual hits that were tested in intracellular calcium mobilization assays of NTS1R agonist and antagonist activities measured in FLIPR format as well as in [3H]NT competition binding studies.  The results indicated that two initial hits produced partial agonist activity with potency in the moderate micromolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-XBoLKqs9Y7Vg90H21EOLACvtfcHk0lj1kwDoghOf0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht12rs77L&md5=1b24b770894b7ad4c19a0dab551f2ae1</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.09.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.09.075%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DY.%26aulast%3DLai%26aufirst%3DM.%2BH.%26aulast%3DSullivan%26aufirst%3DK.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DAndree%26aufirst%3DT.%2BH.%26aulast%3DDollings%26aufirst%3DP.%26aulast%3DPausch%26aufirst%3DM.%2BH.%26atitle%3DThe%2520identification%2520of%2520neurotensin%2520NTS1%2520receptor%2520partial%2520agonists%2520through%2520a%2520ligand-based%2520virtual%2520screening%2520approach%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D5789%26epage%3D5791%26doi%3D10.1016%2Fj.bmcl.2008.09.075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Fruscia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizifard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamenecka, T. M.</span></span> <span> </span><span class="NLM_article-title">The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1) Bioorg</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">3974</span>– <span class="NLM_lpage">3978</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.06.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1016%2Fj.bmcl.2014.06.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=24997685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFWgt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=3974-3978&author=P.+Di%0AFrusciaauthor=Y.+Heauthor=M.+Koenigauthor=S.+Tabrizifardauthor=A.+Nietoauthor=P.+H.+McDonaldauthor=T.+M.+Kamenecka&title=The+discovery+of+indole+full+agonists+of+the+neurotensin+receptor+1+%28NTSR1%29+Bioorg&doi=10.1016%2Fj.bmcl.2014.06.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of indole full agonists of the neurotensin receptor 1 (NTSR1)</span></div><div class="casAuthors">Di Fruscia, Paolo; He, Yuanjun; Koenig, Marcel; Tabrizifard, Sahba; Nieto, Ainhoa; McDonald, Patricia H.; Kamenecka, Theodore M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3974-3978</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Neurotensin (NT) is an endogenous tridecapeptide found in the central nervous system (CNS) and in peripheral tissues.  Neurotensin exerts a wide range of physiol. effects and it has been found to play a crit. role in a no. of human diseases, such as schizophrenia, Parkinson's disease and drug addiction.  The discovery of small-mol. non-peptide neurotensin receptor (NTSR) modulators would represent an important breakthrough as such compds. could be used as pharmacol. tools, to further decipher the cellular functions of neurotensin, and potentially as therapeutic agents to treat human disease.  Herein, we report the identification of non-peptide low-micromolar neurotensin receptor 1 (NTSR1) full agonists, discovered through structural optimization of the known NTSR1 partial agonist 1.  In vitro cellular screenings, based on an intracellular Ca2+ mobilization assay, revealed our best hit mol. 8 (SR-12062) to have an EC50 of 2 μM at NTSR1 with full agonist behavior (Emax = 100%), showing a higher efficacy and ∼90-fold potency improvement compared to parent compd. 1 (EC50 = 178 μM; Emax = 17%).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodSx4caog6BrVg90H21EOLACvtfcHk0lgNI6pfmnyt9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFWgt77O&md5=e1707922eddb096a555bf2aed2d9ff1c</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.06.033%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFruscia%26aufirst%3DP.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DKoenig%26aufirst%3DM.%26aulast%3DTabrizifard%26aufirst%3DS.%26aulast%3DNieto%26aufirst%3DA.%26aulast%3DMcDonald%26aufirst%3DP.%2BH.%26aulast%3DKamenecka%26aufirst%3DT.%2BM.%26atitle%3DThe%2520discovery%2520of%2520indole%2520full%2520agonists%2520of%2520the%2520neurotensin%2520receptor%25201%2520%2528NTSR1%2529%2520Bioorg%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D3974%26epage%3D3978%26doi%3D10.1016%2Fj.bmcl.2014.06.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peddibhotla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milewski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gosalia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugarman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hood, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suyama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heynen-Genel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasile, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salaniwal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stonich, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangravita-Novo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicchiarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barak, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of ML314, a Brain Penetrant Non-Peptidic beta-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1021/ml400176n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400176n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCmu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=846-851&author=S.+Peddibhotlaauthor=M.+P.+Hedrickauthor=P.+Hershbergerauthor=P.+R.+Maloneyauthor=Y.+Liauthor=M.+Milewskiauthor=P.+Gosaliaauthor=W.+Grayauthor=A.+Mehtaauthor=E.+Sugarmanauthor=B.+Hoodauthor=E.+Suyamaauthor=K.+Nguyenauthor=S.+Heynen-Genelauthor=S.+Vasileauthor=S.+Salaniwalauthor=D.+Stonichauthor=Y.+Suauthor=A.+Mangravita-Novoauthor=M.+Vicchiarelliauthor=G.+P.+Rothauthor=L.+H.+Smithauthor=T.+D.+Chungauthor=G.+R.+Hansonauthor=J.+B.+Thomasauthor=M.+G.+Caronauthor=L.+S.+Barakauthor=A.+B.+Pinkerton&title=Discovery+of+ML314%2C+a+Brain+Penetrant+Non-Peptidic+beta-Arrestin+Biased+Agonist+of+the+Neurotensin+NTR1+Receptor&doi=10.1021%2Fml400176n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of ML314, a Brain Penetrant Nonpeptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor</span></div><div class="casAuthors">Peddibhotla, Satyamaheshwar; Hedrick, Michael P.; Hershberger, Paul; Maloney, Patrick R.; Li, Yujie; Milewski, Monika; Gosalia, Palak; Gray, Wilson; Mehta, Alka; Sugarman, Eliot; Hood, Becky; Suyama, Eigo; Nguyen, Kevin; Heynen-Genel, Susanne; Vasile, Stefan; Salaniwal, Sumeet; Stonich, Derek; Su, Ying; Mangravita-Novo, Arianna; Vicchiarelli, Michael; Roth, Gregory P.; Smith, Layton H.; Chung, Thomas D. Y.; Hanson, Glen R.; Thomas, James B.; Caron, Marc G.; Barak, Lawrence S.; Pinkerton, Anthony B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">846-851</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotensin 1 receptor (NTR1) is an important therapeutic target for a range of disease states including addiction.  A high-throughput screening campaign, followed by medicinal chem. optimization, led to the discovery of a nonpeptidic β-arrestin biased agonist for NTR1.  The lead compd., 2-cyclopropyl-6,7-dimethoxy-4-[4-(2-methoxyphenyl)piperazin-1-yl]quinazoline, 32 (I, ML314), exhibits full agonist behavior against NTR1 (EC50 = 2.0 μM) in the primary assay and selectivity against NTR2.  The effect of 32 is blocked by the NTR1 antagonist SR142948A in a dose-dependent manner.  Unlike peptide-based NTR1 agonists, compd. 32 has no significant response in a Ca2+ mobilization assay and is thus a biased agonist that activates the β-arrestin pathway rather than the traditional Gq coupled pathway.  This bias has distinct biochem. and functional consequences that may lead to physiol. advantages.  Compd. 32 displays good brain penetration in rodents, and studies examg. its in vivo properties are underway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxTEeUPENaGbVg90H21EOLACvtfcHk0lihta44hjxNHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCmu7rL&md5=79025bb9edba860732cdeff77a0a506e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fml400176n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400176n%26sid%3Dliteratum%253Aachs%26aulast%3DPeddibhotla%26aufirst%3DS.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DHershberger%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DMilewski%26aufirst%3DM.%26aulast%3DGosalia%26aufirst%3DP.%26aulast%3DGray%26aufirst%3DW.%26aulast%3DMehta%26aufirst%3DA.%26aulast%3DSugarman%26aufirst%3DE.%26aulast%3DHood%26aufirst%3DB.%26aulast%3DSuyama%26aufirst%3DE.%26aulast%3DNguyen%26aufirst%3DK.%26aulast%3DHeynen-Genel%26aufirst%3DS.%26aulast%3DVasile%26aufirst%3DS.%26aulast%3DSalaniwal%26aufirst%3DS.%26aulast%3DStonich%26aufirst%3DD.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DMangravita-Novo%26aufirst%3DA.%26aulast%3DVicchiarelli%26aufirst%3DM.%26aulast%3DRoth%26aufirst%3DG.%2BP.%26aulast%3DSmith%26aufirst%3DL.%2BH.%26aulast%3DChung%26aufirst%3DT.%2BD.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520of%2520ML314%252C%2520a%2520Brain%2520Penetrant%2520Non-Peptidic%2520beta-Arrestin%2520Biased%2520Agonist%2520of%2520the%2520Neurotensin%2520NTR1%2520Receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D846%26epage%3D851%26doi%3D10.1021%2Fml400176n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barak, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evron, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urs, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peddibhotla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedrick, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maloney, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, T. D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1880</span>– <span class="NLM_lpage">1890</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b00291</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b00291" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC28Xmsl2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=1880-1890&author=L.+S.+Barakauthor=Y.+Baiauthor=S.+Petersonauthor=T.+Evronauthor=N.+M.+Ursauthor=S.+Peddibhotlaauthor=M.+P.+Hedrickauthor=P.+Hershbergerauthor=P.+R.+Maloneyauthor=T.+D.+Y.+Chungauthor=R.+M.+Rodriguizauthor=W.+C.+Wetselauthor=J.+B.+Thomasauthor=G.+R.+Hansonauthor=A.+B.+Pinkertonauthor=M.+G.+Caron&title=ML314%3A+A+Biased+Neurotensin+Receptor+Ligand+for+Methamphetamine+Abuse&doi=10.1021%2Facschembio.6b00291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse</span></div><div class="casAuthors">Barak, Larry S.; Bai, Yushi; Peterson, Sean; Evron, Tama; Urs, Nikhil M.; Peddibhotla, Satyamaheshwar; Hedrick, Michael P.; Hershberger, Paul; Maloney, Patrick R.; Chung, Thomas D. Y.; Rodriguiz, Ramona M.; Wetsel, William C.; Thomas, James B.; Hanson, Glen R.; Pinkerton, Anthony B.; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1880-1890</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pharmacol. treatment for methamphetamine addiction will provide important societal benefits.  Neurotensin receptor NTR1 and dopamine receptor distributions coincide in brain areas regulating methamphetamine-assocd. reward, and neurotensin peptides produce behaviors opposing psychostimulants.  Therefore, undesirable methamphetamine-assocd. activities should be treatable with druggable NTR1 agonists, but no such FDA-approved therapeutics exist.  We address this limitation with proof-of-concept data for ML314, a small-mol., brain penetrant, β-arrestin biased, NTR1 agonist.  ML314 attenuates amphetamine-like hyperlocomotion in dopamine transporter knockout mice, and in C57BL/6J mice it attenuates methamphetamine-induced hyperlocomotion, potentiates the psychostimulant inhibitory effects of a ghrelin antagonist, and reduces methamphetamine-assocd. conditioned place preference.  In rats, ML314 blocks methamphetamine self-administration.  ML314 acts as an allosteric enhancer of endogenous neurotensin, unmasking stoichiometric nos. of hidden NTR1 binding sites in transfected-cell membranes or mouse striatal membranes, while addnl. supporting NTR1 endocytosis in cells in the absence of NT peptide.  These results indicate ML314 is a viable, preclin. lead for methamphetamine abuse treatment and support an allosteric model of G protein-coupled receptor signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRELv0YzCr9bVg90H21EOLACvtfcHk0ljrf0jZrZiUhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xmsl2rtbY%253D&md5=48872ea73457f91e63a8631117848ecd</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b00291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b00291%26sid%3Dliteratum%253Aachs%26aulast%3DBarak%26aufirst%3DL.%2BS.%26aulast%3DBai%26aufirst%3DY.%26aulast%3DPeterson%26aufirst%3DS.%26aulast%3DEvron%26aufirst%3DT.%26aulast%3DUrs%26aufirst%3DN.%2BM.%26aulast%3DPeddibhotla%26aufirst%3DS.%26aulast%3DHedrick%26aufirst%3DM.%2BP.%26aulast%3DHershberger%26aufirst%3DP.%26aulast%3DMaloney%26aufirst%3DP.%2BR.%26aulast%3DChung%26aufirst%3DT.%2BD.%2BY.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DThomas%26aufirst%3DJ.%2BB.%26aulast%3DHanson%26aufirst%3DG.%2BR.%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DML314%253A%2520A%2520Biased%2520Neurotensin%2520Receptor%2520Ligand%2520for%2520Methamphetamine%2520Abuse%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D1880%26epage%3D1890%26doi%3D10.1021%2Facschembio.6b00291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Hershberger, P. M.</span>; <span class="NLM_string-name">Peddibhotla, S.</span>; <span class="NLM_string-name">Maloney, P. R.</span>; <span class="NLM_string-name">Hedrick, M. P.</span></span> <span> </span><span class="NLM_article-title">Preparation of substituted quinazolines as small molecule agonists of neurotensin receptor 1</span>. PCT WO <span class="NLM_patent">2015200534</span>, Dec 30, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=A.+B.+Pinkerton&author=P.+M.+Hershberger&author=S.+Peddibhotla&author=P.+R.+Maloney&author=M.+P.+Hedrick&title=Preparation+of+substituted+quinazolines+as+small+molecule+agonists+of+neurotensin+receptor+1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DPinkerton%26aufirst%3DA.%2BB.%26atitle%3DPreparation%2520of%2520substituted%2520quinazolines%2520as%2520small%2520molecule%2520agonists%2520of%2520neurotensin%2520receptor%25201%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hershberger, P.</span>; <span class="NLM_string-name">Hedrick, M.</span>; <span class="NLM_string-name">Peddibhotla, S.</span>; <span class="NLM_string-name">Maloney, P.</span>; <span class="NLM_string-name">Li, Y.</span>; <span class="NLM_string-name">Milewski, M.</span>; <span class="NLM_string-name">Gosalia, P.</span>; <span class="NLM_string-name">Gray, W.</span>; <span class="NLM_string-name">Mehta, A.</span>; <span class="NLM_string-name">Sugarman, E.</span>; <span class="NLM_string-name">Hood, B.</span>; <span class="NLM_string-name">Suyama, E.</span>; <span class="NLM_string-name">Nguyen, K.</span>; <span class="NLM_string-name">Heynen-Genel, S.</span>; <span class="NLM_string-name">Vasile, S.</span>; <span class="NLM_string-name">Salaniwal, S.</span>; <span class="NLM_string-name">Stonich, D.</span>; <span class="NLM_string-name">Su, Y.</span>; <span class="NLM_string-name">Mangravita-Novo, A.</span>; <span class="NLM_string-name">Vicchiarelli, M.</span>; <span class="NLM_string-name">Smith, L. H.</span>; <span class="NLM_string-name">Roth, G.</span>; <span class="NLM_string-name">Diwan, J.</span>; <span class="NLM_string-name">Chung, T. D. Y.</span>; <span class="NLM_string-name">Caron, M. G.</span>; <span class="NLM_string-name">Thomas, J. B.</span>; <span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Barak, L. R.</span></span> <span> </span><span class="NLM_article-title">Small Molecule Agonists for the Neurotensin 1 Receptor (NTR1 Agonists)</span>.  <i>Probe Reports from the NIH Molecular Libraries Program</i>; <span class="NLM_publisher-name">U.S. National Center for Biotechnology Information</span>, <span class="NLM_year">2010</span>–<span class="NLM_year">2012</span>; <a href="https://pubchem.ncbi.nlm.nih.gov/bioassay/493036" class="extLink">https://pubchem.ncbi.nlm.nih.gov/bioassay/493036</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=P.+Hershberger&author=M.+Hedrick&author=S.+Peddibhotla&author=P.+Maloney&author=Y.+Li&author=M.+Milewski&author=P.+Gosalia&author=W.+Gray&author=A.+Mehta&author=E.+Sugarman&author=B.+Hood&author=E.+Suyama&author=K.+Nguyen&author=S.+Heynen-Genel&author=S.+Vasile&author=S.+Salaniwal&author=D.+Stonich&author=Y.+Su&author=A.+Mangravita-Novo&author=M.+Vicchiarelli&author=L.+H.+Smith&author=G.+Roth&author=J.+Diwan&author=T.+D.+Y.+Chung&author=M.+G.+Caron&author=J.+B.+Thomas&author=A.+B.+Pinkerton&author=L.+R.+Barak&title=Small+Molecule+Agonists+for+the+Neurotensin+1+Receptor+%28NTR1+Agonists%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3DHershberger%26aufirst%3DP.%26atitle%3DSmall%2520Molecule%2520Agonists%2520for%2520the%2520Neurotensin%25201%2520Receptor%2520%2528NTR1%2520Agonists%2529%26jtitle%3DProbe%2520Reports%2520from%2520the%2520NIH%2520Molecular%2520Libraries%2520Program%26pub%3DU.S.%2520National%2520Center%2520for%2520Biotechnology%2520Information%26date%3D2010%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slosky, L. M.</span>; <span class="NLM_string-name">Bai, Y.</span>; <span class="NLM_string-name">Toth, K.</span>; <span class="NLM_string-name">Rochelle, L. K.</span>; <span class="NLM_string-name">Ray, C.</span>; <span class="NLM_string-name">Badea, A.</span>; <span class="NLM_string-name">Pogorelov, V.</span>; <span class="NLM_string-name">Chandrasekhar, R.</span>; <span class="NLM_string-name">Abraham, D. M.</span>; <span class="NLM_string-name">Atluri, N.</span>; <span class="NLM_string-name">Peddibhotla, S.</span>; <span class="NLM_string-name">Hedrick, M. P.</span>; <span class="NLM_string-name">Hershberger, P.</span>; <span class="NLM_string-name">Maloney, P.</span>; <span class="NLM_string-name">Yuan, H.</span>; <span class="NLM_string-name">Li, Z.</span>; <span class="NLM_string-name">Wetsel, W.</span>; <span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Barak, L.</span>; <span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Allosteric Neurotensin Receptor 1 Modulator Confers β-arrestin Bias and Selectively Attenuates Addiction-Associated Behaviors</span>. Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Slosky%2C+L.+M.%3B+Bai%2C+Y.%3B+Toth%2C+K.%3B+Rochelle%2C+L.+K.%3B+Ray%2C+C.%3B+Badea%2C+A.%3B+Pogorelov%2C+V.%3B+Chandrasekhar%2C+R.%3B+Abraham%2C+D.+M.%3B+Atluri%2C+N.%3B+Peddibhotla%2C+S.%3B+Hedrick%2C+M.+P.%3B+Hershberger%2C+P.%3B+Maloney%2C+P.%3B+Yuan%2C+H.%3B+Li%2C+Z.%3B+Wetsel%2C+W.%3B+Pinkerton%2C+A.+B.%3B+Barak%2C+L.%3B+Caron%2C+M.+G.+Allosteric+Neurotensin+Receptor+1+Modulator+Confers+%CE%B2-arrestin+Bias+and+Selectively+Attenuates+Addiction-Associated+Behaviors.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DSlosky%26aufirst%3DL.%2BM.%26atitle%3DAllosteric%2520Neurotensin%2520Receptor%25201%2520Modulator%2520Confers%2520%25CE%25B2-arrestin%2520Bias%2520and%2520Selectively%2520Attenuates%2520Addiction-Associated%2520Behaviors" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span> <i>NT1
Human Neurotensin GPCR Binding (Agonist Radioligand) Assay, Panlabs</i>; <span class="NLM_publisher-name">Eurofins</span>, <span class="NLM_year">2019</span>; <a href="https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/NT1-Human-Neurotensin-GPCR-Binding-Agonist-Radioligand-Assay-Panlabs/258010" class="extLink">https://www.eurofinsdiscoveryservices.com/catalogmanagement/viewitem/NT1-Human-Neurotensin-GPCR-Binding-Agonist-Radioligand-Assay-Panlabs/258010</a> (accessed August 1, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+NT1%0AHuman+Neurotensin+GPCR+Binding+%28Agonist+Radioligand%29+Assay%2C+Panlabs%3B+Eurofins%2C+2019%3B+https%3A%2F%2Fwww.eurofinsdiscoveryservices.com%2Fcatalogmanagement%2Fviewitem%2FNT1-Human-Neurotensin-GPCR-Binding-Agonist-Radioligand-Assay-Panlabs%2F258010+%28accessed+August+1%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DNT1%250AHuman%2520Neurotensin%2520GPCR%2520Binding%2520%2528Agonist%2520Radioligand%2529%2520Assay%252C%2520Panlabs%26pub%3DEurofins%26date%3D2019%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Efimova, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gainetdinov, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budygin, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sotnikova, T. D.</span></span> <span> </span><span class="NLM_article-title">Dopamine transporter mutant animals: a translational perspective</span>. <i>J. Neurogenet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">5</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.3109/01677063.2016.1144751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.3109%2F01677063.2016.1144751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=27276191" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADC%252BC28Xpslyis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=5-15&issue=1&author=E.+V.+Efimovaauthor=R.+R.+Gainetdinovauthor=E.+A.+Budyginauthor=T.+D.+Sotnikova&title=Dopamine+transporter+mutant+animals%3A+a+translational+perspective&doi=10.3109%2F01677063.2016.1144751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine transporter mutant animals: a translational perspective</span></div><div class="casAuthors">Efimova, Evgeniya V.; Gainetdinov, Raul R.; Budygin, Evgeny A.; Sotnikova, Tatyana D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-15</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The dopamine transporter (DAT) plays an important homeostatic role in the control of both the extracellular and intraneuronal concns. of dopamine, thereby providing effective control over activity of dopaminergic transmission.  Since brain dopamine is known to be involved in numerous neuropsychiatric disorders, investigations using mice with genetically altered DAT function and thus intensity of dopamine-mediated signaling have provided numerous insights into the pathol. of these disorders and novel pathol. mechanisms that could be targeted to provide new therapeutic approaches for these disorders.  In this brief overview, we discuss recent investigations involving animals with genetically altered DAT function, particularly focusing on translational studies providing new insights into pathol. and pharmacol. of dopamine-related disorders.  Perspective applications of these and newly developed models of DAT dysfunction are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUioooqPwsCLVg90H21EOLACvtfcHk0lh32YYJgdti1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xpslyis7s%253D&md5=44131a75927bf32f40d580fff0b825e0</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.3109%2F01677063.2016.1144751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2016.1144751%26sid%3Dliteratum%253Aachs%26aulast%3DEfimova%26aufirst%3DE.%2BV.%26aulast%3DGainetdinov%26aufirst%3DR.%2BR.%26aulast%3DBudygin%26aufirst%3DE.%2BA.%26aulast%3DSotnikova%26aufirst%3DT.%2BD.%26atitle%3DDopamine%2520transporter%2520mutant%2520animals%253A%2520a%2520translational%2520perspective%26jtitle%3DJ.%2520Neurogenet.%26date%3D2016%26volume%3D30%26issue%3D1%26spage%3D5%26epage%3D15%26doi%3D10.3109%2F01677063.2016.1144751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giros, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wightman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, M. G.</span></span> <span> </span><span class="NLM_article-title">Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>379</i></span> (<span class="NLM_issue">6566</span>),  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">612</span>, <span class="refDoi"> DOI: 10.1038/379606a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=10.1038%2F379606a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=8628395" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;key=1%3ACAS%3A528%3ADyaK28XhtFKrurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=606-612&issue=6566&author=B.+Girosauthor=M.+Jaberauthor=S.+R.+Jonesauthor=R.+M.+Wightmanauthor=M.+G.+Caron&title=Hyperlocomotion+and+indifference+to+cocaine+and+amphetamine+in+mice+lacking+the+dopamine+transporter&doi=10.1038%2F379606a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter</span></div><div class="casAuthors">Giros, Bruno; Jaber, Mohamed; Jones, Sara R.; Wightman, R. Mark; Caron, Marc G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6566</span>),
    <span class="NLM_cas:pages">606-12</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">Disruption of the mouse dopamine transporter gene results in spontaneous hyperlocomotion despite major adaptive changes, such as decreases in neurotransmitter and receptor levels.  In homozygote mice, dopamine persists at least 100 times longer in the extracellular space, explaining the biochem. basis of the hyperdopaminergic phenotype and demonstrating the crit. role of the transporter in regulating neurotransmission.  The dopamine transporter is an obligatory target of cocaine and amphetamine, as these psychostimulants have no effect on locomotor activity or dopamine release and uptake in mice lacking the transporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_SzRLVUlNDbVg90H21EOLACvtfcHk0lh32YYJgdti1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFKrurg%253D&md5=b502613d49de0d2a3f80967440ece1a4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2F379606a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379606a0%26sid%3Dliteratum%253Aachs%26aulast%3DGiros%26aufirst%3DB.%26aulast%3DJaber%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DS.%2BR.%26aulast%3DWightman%26aufirst%3DR.%2BM.%26aulast%3DCaron%26aufirst%3DM.%2BG.%26atitle%3DHyperlocomotion%2520and%2520indifference%2520to%2520cocaine%2520and%2520amphetamine%2520in%2520mice%2520lacking%2520the%2520dopamine%2520transporter%26jtitle%3DNature%26date%3D1996%26volume%3D379%26issue%3D6566%26spage%3D606%26epage%3D612%26doi%3D10.1038%2F379606a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krumm, B. E.</span>; <span class="NLM_string-name">DiBerto, J. F.</span>; <span class="NLM_string-name">Olsen, R. H. J.</span>; <span class="NLM_string-name">Kang, H. J.</span>; <span class="NLM_string-name">Che, T.</span>; <span class="NLM_string-name">Slocum, S. T.</span>; <span class="NLM_string-name">Strachan, R. T.</span>; <span class="NLM_string-name">Slosky, L. M.</span>; <span class="NLM_string-name">Pinkerton, A. B.</span>; <span class="NLM_string-name">Barak, L. S.</span>; <span class="NLM_string-name">Caron, M. G.</span>; <span class="NLM_string-name">Kenakin, T.</span>; <span class="NLM_string-name">Roth, B.
L.</span></span> <span> </span><span class="NLM_article-title">Neurotensin receptor allosterism revealed in complex with a biased allosteric modulator</span>. Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Krumm%2C+B.+E.%3B+DiBerto%2C+J.+F.%3B+Olsen%2C+R.+H.+J.%3B+Kang%2C+H.+J.%3B+Che%2C+T.%3B+Slocum%2C+S.+T.%3B+Strachan%2C+R.+T.%3B+Slosky%2C+L.+M.%3B+Pinkerton%2C+A.+B.%3B+Barak%2C+L.+S.%3B+Caron%2C+M.+G.%3B+Kenakin%2C+T.%3B+Roth%2C+B.%0AL.+Neurotensin+receptor+allosterism+revealed+in+complex+with+a+biased+allosteric+modulator.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dunpublished%26sid%3Dliteratum%253Aachs%26aulast%3DKrumm%26aufirst%3DB.%2BE.%26atitle%3DNeurotensin%2520receptor%2520allosterism%2520revealed%2520in%2520complex%2520with%2520a%2520biased%2520allosteric%2520modulator" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i22"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00340">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80273"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00340">10.1021/acs.jmedchem.9b00340</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures and spectroscopic data for selected compounds, details of the PK studies, and assay protocols for the binding studies. (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_001.pdf">jm9b00340_si_001.pdf (5.2 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00340/suppl_file/jm9b00340_si_002.csv">jm9b00340_si_002.csv (3.53 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00340&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-17%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00340%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00340" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991bfc8b4f2332","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
